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                                 INTRODUCTION  
Short surgical procedures like Fibroadenoma excision are commonly 
performed as a daycare procedure which demands short, safe and effective  
balanced anaesthesia.  
             Volatile anesthetics are commonly used for the maintenance of 
anesthesia nowadays. Diethyl ether was the first agent used in the history of 
volatile anaesthesia followed by Nitrous oxide to the most modern volatile 
anaesthetics like Desflurane and Sevoflurane1. These modern volatile 
anaesthetics form an important tool in patients undergoing general anaesthesia 
by altering central nervous system functions. In 1950, all halogenated older 
anaesthetics were withdrawn due to their hepatotoxicity except Nitrous oxide. 
The newer inhaled anaesthetics that are available today are introduced by 
replacing fluoride to hydrogen atom.  
            Desflurane and Sevoflurane with low blood-gas partition co-
efficients have facilitated rapid induction of anaesthesia, precise control 
of end-tidal concentration during maintenance of anaesthesia and rapid 
recovery and less airway adverse effects at the end of anaesthesia.  The 
rapid induction, recovery and clinical acceptance of Desflurane and 
Sevoflurane led to their use in daycare surgery.   
 2  
  
Economic [cost] factor is an important consideration in the practice of 
these newer anaesthetics which can be decreased by effective anaesthetic 
techniques like low flow anaesthesia..   
So, in this study we decided to compare the recovery profile, emergence, 
airway adverse effects and haemodynamic parameters of Desflurane and 
sevoflurane using a balanced anaesthesia technique. 
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AIM OF THE STUDY 
To compare the Emergence, Recovery, Airway adverse effects and 
Haemodynamic parameters (Heart rate and Mean arterial pressure) between 
Desflurane and Sevoflurane in Fibroadenoma excision under General 
Anaesthesia using Proseal LMA with spontaneous respiration.   
PRIMARY OBJECTIVE:   
Primary objective in the study was to compare the Emergence, Recovery  
characteristics and Airway adverse effects  of Desflurane and  Sevoflurane 
SECONDARY OBJECTIVE:  
The secondary objective was to assess the intraoperative variability of 
Heart rate and Mean Arterial Pressure of two groups anaesthetised with either 
Desflurane or Sevoflurane. 
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REVIEW OF LITERATURE 
                  S.Gergin B.Cevik et al did a randomised comparative study to 
compare hemodynamic changes, emergence and recovery characteristics of 
Sevoflurane and Desflurane in Laparoscopic cholecystectomy cases. 40 
patients were selected and randomized into two groups. After standardized 
induction sequence and intubation, patients were maintained under anaesthesia 
with either 1% Sevoflurane or 3% Desflurane. They concluded that Desflurane 
had faster recovery and emergence when compared to Sevoflurane. 
Haemodynamic changes were comparable between both the groups2. 
Klock PA, Czeslick EG did a randomized comparative study of 64 
patients of ASA PS I and II, comparing Desflurane and Sevoflurane in range of 
1 to  1.8 MAC in day care surgeries. They assessed upper airway reactivity and 
haemodynamic changes between  Desflurane and sevoflurane. They  concluded 
that at 1 MAC Desflurane had upper airway reactivity such as  coughing and 
associated Heamodynamic changes (both at p <0.05). At  1.8 MAC Desflurane 
and Sevoflurane both caused  Heamodynamic changes(BP fall and 
bradycardia) but do not cause any upper airway reactivity3. 
  White PF et al did a randomized control study to compare effects of 
Desflurane with Sevoflurane in  maintenance of general anaesthesia in  
ambulatory surgery. They selected 130 patients undergoing superficial surgical 
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procedures requiring general anaesthesia and randomized them into two 
groups. The patients were induced with Propofol and a laryngeal mask airway 
was placed followed by maintenance with either Sevoflurane 1-3% or 
Desflurane 3-8% in air/ oxygen mixture.  They assessed the Recovery time to 
eye opening, response to commands, orientation, fast-track score of 14, first 
oral intake, sitting, standing, ambulating unassisted, actual discharge and 
postoperative complications like cough. They concluded that Desflurane had 
faster recovery with high incidence of cough4.  
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Nathanson MH et al   did a  randomized comparative study comparing   the 
Recovery characteristics of Desflurane and Sevoflurane used for maintenance in 
42 women undergoing Laparoscopic sterilization procedures. Based on adequate 
depth of anaesthesia and to maintain Mean arterial pressure (MAP) within 20% of 
the pre-induction baseline values, agents were titrated. Visual analogue scale 
(VAS) and the digit-symbol substitution test (DSST) were done preoperatively and 
at 30 minutes intervals during post-op recovery period. They  concluded that 
Desflurane leads to a more rapid Emergence compared to that of Sevoflurane. 
However,  Recovery time, postoperative VAS and DSST scores, and side effects 
were similar in the both groups5.  
   Mckay RE,  compared airway response during Desflurane and Sevoflurane 
administration using laryngeal mask airway in  110 patients who were smokers and 
divided into two groups of  55  each. They compared coughing, breath holding, 
laryngospasm and desaturation in both the groups. This study concluded that 
coughing, breath holding were more common during Emergence at lower 
anaesthetic concentration  of Desflurane and Sevoflurane. Airway adverse effects 
were comparable in both groups  and respiratory complications were more 
common with smokers6. 
          HYUN _JOUNG NO did a retrospective cohort study of perioperative 
upper respiratory events in children undergoing general anaesthesia using 
Desflurane and  Sevoflurane through supraglottic airway. This  retrospective study 
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evaluated 3499 children of age 1 to 15 years .This study concluded that there was 
no significant difference  in perioperative respiratory events between the two 
groups7 . 
                 A study conducted by Dupont et al compared  Maintenance and 
Recovery profile after general anaesthesia with Sevoflurane, Desflurane and 
Isoflurane in 100 patients undergoing pulmonary surgery. This study showed that 
the three anaesthetics had comparable haemodynamic effects and arterial 
oxygenation during one-lung ventilation. Emergence was twice as fast with 
Desflurane as with Sevoflurane or Isoflurane. Aldrete score, cognitive and 
psychomotor functions were faster with Desflurane8.   
                    Isik Y et al did a randomized control study of low flow Desflurane 
and Sevoflurane  anaesthesia in children. In this study they included 80 patients in 
the age group of 5-15 yr. Induction of anaesthesia was done with Propofol and 
Endotracheal intubation was facilitated with Atracurium. Desflurane  group was 
maintained with Desflurane, oxygen and nitrous oxide  and Sevoflurane group was 
maintained with Sevoflurane, oxygen and nitrous oxide.  Intraoperative heart rate 
variability and Mean arterial pressure variability ,preoperative and postoperative 
hepatic and renal functions ,the total duration of anaesthesia and surgery ,early 
recovery parameters were recorded.The modified PARS score recorded at 10th  and 
30 th   minutes postoperatively and postoperative nausea and vomiting were 
assessed.They concluded that low flow Desflurane and Sevoflurane anaesthesia 
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did not adversely affect the intraoperative haemodynamic values, LFT and RFT in 
children and preferred Desflurane as it has early recovery from anaesthesia9.  
 McKay RE et al conducted a study on awareness and return of  Airway 
reflexes after Desflurane anaesthesia and  Sevoflurane anaesthesia.  A  total of  64 
patients were randomized to receive Desflurane (n = 31) or Sevoflurane    (n=33) 
via a laryngeal mask airway.  The time from stopping inhalational anaesthetic  to  
response to  oral commands, ability to  swallow  20 ml of water without coughing 
or drooling were observed in both the groups. They concluded that from the time 
of cutting inhalational anaesthetic  to the first response to oral command was  
significantly longer with Sevoflurane.  At 2 minutes after responding to oral 
commands,  all patients in Desflurane group were able to swallow without 
drooling or coughing but  55% of patients with Sevoflurane drooled and 
coughed10.   
  L. E. C. De Baerdemaeker et al  conducted a study in 50 morbidly obese 
patients  undergoing Laproscopic gastroplasty and compared the  optimization of 
Desflurane administration with Sevoflurane using an ‘inhalation bolus’ technique. 
They assessed the depth of anaesthesia, haemodynamic stability, and Recovery 
time in both the groups using Bispectral index.   They concluded that immediate 
recovery was significantly faster in the Desflurane group. Overall hypnotic 
controllability measured by BIS was less accurate with Desflurane. Overall 
haemodynamic controllability was better with Desflurane. The use of an inhalation 
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bolus was found to be appropriate in both the groups without causing severe 
heamodynamic side effects11.   
  JY Park et al did a comparison of consumption and recovery Profiles 
according to anaesthetic circuit Mode using a New Multifunctional Closed-Circuit 
Anaesthesia System during Desflurane Anaesthesia. This clinical study was 
conducted in 60 female patients undergoing Gynaecological procedures and total 
induction time, anaesthetic dose consumed  and haemodynamic and Recovery 
profiles were studied. Three groups were randomly assigned to receive Desflurane 
anaesthesia through closed circuit and semi-closed circuit at fresh gas flow rates of 
4 l/min  and 2 l/min . Inhalational anaesthetics were maintained at Minimum 
alveolar concentration BAR.. The time required to reach MACBAR was significantly 
shorter and the dose of Desflurane required was significantly less in the CC group 
when compared with the other groups.  There was no statistical difference in 
haemodynamic and recovery profiles between the two groups.They concluded that 
the CC mode allowed a faster and more reliable induction, lower anaesthetic 
consumption and stable haemodynamic and recovery profiles12.  
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                                                HISTORICAL REVIEW 
HISTORY OF VOLATILE ANAESTHETICS  
The history of volatile anaesthetics falls way back to 1772 when Joseph  
Priestely prepared Nitrous Oxide followed by Humphry Davy, who recognised  
Nitrous oxide’s anaesthetic  properties and used them in dental surgeries for pain 
relief. JAMES YOUNG SIMPSON, an obstetrician introduced chloroform in 
1831 in obstetric practice13. 
In 1842, Diethyl ether was first used as an anaesthetic by WILLIAM 
CLARKE, which was used previously for treating whooping cough and other 
respiratory ailments. On October 16th 1846, a dentist of Boston origin,  William 
T.G. Morton, first did public demonstration of the ether anaesthesia on a patient 
and excised a tumour from  his jaw. This day is celebrated as “ETHER DAY” or 
"WORLD ANAESTHESIA DAY”.  
In 1950, all halogenated older anaesthetics except Nitrous oxide were 
withdrawn due to their inflammability and potential hepatotoxicity. 
             This is followed by Methoxyflurane and Enflurane which were 
withdrawn from market due to organ toxicity. Isoflurane, chemically a 
halogenated methyl ethyl ether and in 1981 Enflurane isomer was introduced 
which has least arrythmogenic potential.  
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                Desflurane, a fluorinated methyl ethyl ether was introduced in 1992 by 
Dr.Ross terell followed by the introduction of Sevoflurane in 1994, a fluorinated 
mehyl isopropyl ether13.  
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                                 PHARMACOLOGY: 
 
DESFLURANE: 
 
Desflurane a fluorinated methyl ethyl ether.  
CHEMICAL NAME: 1,2,2,2-tetrafluoroethyl difluoromethyl ether    
Figure 1: DESFLURANE STRUCTURE  
 
PHYSICAL AND CHEMICAL PROPERTIES 
• The molecular weight of Desflurane is 168  
• Density is 1.465g/cm3 at 20ºC  
• Boils at 22.8ºC.   
• It has a high vapour pressure of 669 mm Hg at 20ºC.  
• It is pungent  smelling.  
• Minimum alveolar concentration (MAC) of 6.6.   
• Low blood-gas partition co-efficient of 0.42.  
• Oil-gas partition coefficient of 19.  
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PHARMACOKINETICS: 
 
                                          Desflurane has the lowest blood gas solubility of all 
volatile anaesthetic and thus results in faster induction and recovery. 
                                         The distribution of Desflurane follows a five 
compartment model which may be as follows_the  lungs, the vessel rich organs, fat 
around the vessel rich organs  and finally peripheral fat. 
                                        Desflurane undergoes minimal metabolism which is seen 
by increased serum and urinary trifluroacetate. 
                                     The elimination of Desflurane is  faster and it is almost 
exclusively through the lungs, with metabolism by the liver estimated to be less 
than 0.02%. 
PHARMACODYNAMICS:  
CNS EFFECTS: Desflurane causes dose dependent cerebral vasodilation, thus 
increasing CBF, cerebral blood volume and intracranial pressure at normotension 
and normocapnia.  
There is marked reduction in cerebral metabolic rate of O2 .  
It produces a dose dependent burst suppression of the EEG at concentrations 
greater than 1.24 MAC and at a MAC of greater than 1.66 the EEG becomes 
isoelectric. 
CVS EFFECTS: Desflurane causes a dose dependent tachychardia.  
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 It causes   myocardial depression  and decrease in the SVR resulting from 
peripheral vasodilation. These changes occur at concentration ranging from 0.83 to 
1.66 MAC. Desflurane is a also a direct coronary vasodilator and produces overall 
reduction in cardiac work. 
RESPIRATORY EFFECTS: Desflurane is a potent respiratory depressant. 
Desflurane causes decrease in tidal volume and increase in respiratory rate with 
overall reduction in minute alveolar ventilation.  
Desflurane is unsuitable for an inhalational induction because it is extremely 
irritating to the airway due to its pungent odour. 
RENAL EFFECTS: Renal blood flow is reduced and thus Glomerular filtration 
rate and urine output are reduced. 
HEPATIC EFFECTS: It causes decrease in hepatic blood flow and increase in 
portal vein blood flow. 
NEUROMUSCULAR EFFECTS: It is associated with dose dependent decrease in 
response to train of four and tetanic peripheral nerve stimulation. It potentiates the 
action of non depolarizing muscle relaxants.   
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 DESFLURANE VAPOURIZER:  
Since Desflurane has a boiling point of 220c which is room temperature and 
the MAC is high, a special vaporizer is required for its delivery . 
The vapouriser is electrically heated, dual circuit gas vapor blender which 
heats Desflurane to 39oc increasing its SVP to 1300 mmHg.  
 Figure 2: DESFLURANE VAPORISER  
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Figure 3: MEASURED FLOW VAPORISER  
  
  
  
  
Concerns of Desflurane:  
  High cost, low potency, pungency.   
 Airway irritability is seen. So, it is unsuitable for inhalational induction.  
 Desflurane reacts with the desiccant soda lime and produce carbon monoxide.  
 It can cause tachycardia because of sympathetic stimulation13,14,15.  
 
 
 
 
 
 
 17 
 
 
 
SEVOFLURANE:  
  
Sevoflurane is a fluorinated methyl isopropyl ether.  
CHEMICAL NAME: 2,2,2-trifluoro-1-[trifluoromethyl]-ethyl-fluoromethyl- 
ether.   
Figure4:SEVOFLURANESTRUCTURE 
 
PHYSICAL AND CHEMICAL PROPERTIES:  
• The molecular weight of Sevoflurane is 200  
•  Density is 1.517- 1.522g/cm3 at 20ºC   
• Boils at 58.5ºC.   
• It has a vapour pressure of 170mm Hg at 20ºC.  
• It is a sweet-smelling agent.  
• Minimum alveolar concentration (MAC) of 1.8.   
• Low blood-gas partition co-efficient of 0.69.  
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• Oil-gas partition coefficient of 55. 
•  It has a sweet smell which makes it the agent of choice for inhalational induction. 
PHARMACOKINETICS: 
                                  Sevoflurane is a  low soluble inhalational anaesthetic agent 
with Blood:gas partition coefficient of 0.69 and Brain blood partition coefficient of 
1.7 causing rapid induction and recovery 
Its distribution  follows 5 compartmental model consists of lungs,vessel rich 
organs group (brain,liver) and muscle rich group (muscle and skin), fat group and 
vessel poor group(bone,cartilage)   
              Sevoflurane is eliminated 95% unchanged through lungs and 5% 
undergoes hepatic metabolism. Hepatic metabolism results in the formation of 
inorganic fluorides and is rapidly excreted by kidneys. 
PHARMACODYNAMICS OF SEVOFLURANE: 
CNS EFFECTS:  
             Sevoflurane is the least cerebral vasodilating agent and preserves 
autoregulation upto 2 MAC. 
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Cerebral blood flow(CBF) increases with sevoflurane to 11.5 ml/100 gms/dl which 
is less than other volatile anaesthetics except isoflurane. 
CMRO2 is reduced and causes slight increase in Intracranial tension. 
CVS EFFECTS:  
It causes dose dependent fall in systemic vascular resistance and it decreases 
myocardial contractility therefore fall in Blood pressure. 
It has myocardial protectivity by causing coronary vasodilation.  
RESPIRATORY EFFECTS: 
It causes dose dependent decrease in tidal volume and causes rapid shallow 
breathing. 
It can cause increase in Paco2 . 
It has bronchodilator effects and it has sweet odour making it’s a agent of choice 
for inhalational induction. 
HEPATIC EFFECTS: 
It has very little effect on hepatic blood flow. 
RENAL EFFECTS: 
It causes decrease in Renal blood flow,Glomerular filtration rate and urine output. 
It reacts with sodalime and baralime and compound A is produced.  
Compound A may be  nephrotoxic particularly at low fresh gas flows however it is 
not proved in Humans.   
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Figure 5: SEVOFLURANE VAPOURISER 
 
 
  
Sevoflurane vaporiser is a  variable bypass vaporisers. 
It works by controlling rate of vaporisation of agents from liquid and then 
accurately controlling the amount of vapour  to be added to the fresh gas flow.  
Figure 6: VARIABLE BYPASS VAPORISER 
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LIMITATIONS 
 Sevoflurane after prolonged exposure especially in low fresh gas flows reacts with 
soda lime components and produces Compound A and fluoride by-products which 
are potentially toxic.   
 Accumulation of Compound A and fluoride causes nephrotoxicity in rats but, this 
is not proven to be toxic in humans.  
 >800ppm is clinically significant amount to cause nephrotoxicity.  
 Minimum fresh gas flow of 2l/min is required13,14.  
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NITROUS OXIDE:  
 CHEMICAL NAME: Dinitrogen monoxide  
 The molecular weight of Nitrous oxide is 44g.  
PHYSICAL AND CHEMICAL PROPERTIES: 
 Density is 1.517- 1.522g/cm3 at 20ºC   
 Boiling Point: -88°C  
 Critical temperature is 36.5ºC.  
 Minimum alveolar concentration (MAC) of 105.   
 Low blood-gas partition co-efficient of 0.47.  
 Oil-gas partition coefficient of 1.4.  
 Liquefying Pressure (36.5°C): 74 bar / 72 bar  
 Vapour Pressure (20°C): 52 bar 39,000 mmHg  
 Normal Cylinder Pressure: 52 bar  
GENERAL CHARACTERISTICS:  
• N2O is a colourless gas, without odour or taste  
• Steel cylinders are used for their storage, they are present in the liquid state.   
• The normal filling ratio = 0.65  
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• The gas is neither inflammable, nor explosive  
• Rapidly and predominantly eliminated unchanged through the lungs  
• PHARMACOKINETICS: 
It is least potent of all anaesthetic agents with Blood:Gas partition coefficient  of 
0.46  and Blood:brain partition coefficient of 1.3 
Brain concentration occurs by displacement of N2 by N2O usually in 3 to 5 minutes 
Tissue with greater blood flow receive greater amounts of N2O and poor blood 
supply absorb small amounts 
Absorption slows down once primary saturation is achieved  
It has no biotransformation in the body and majority leaves unchanged in 3 to 5 
minutes 
1% eliminated via skin and lungs 
PHARMACODYNAMICS OF NITROUS OXIDE: 
CENTRAL NERVOUS SYSTEM: 
Mild depression of cerebral cortex in conjunction with physiological levels of o2 
Sensations such as sight, hearing, touch are depressed 
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CARDIOVASCULAR EFFECTS: 
No changes in heart rate or cardiac output 
Blood pressure remains stable 
RESPIRATORY SYSTEM: 
N2O is non irritating to pulmonary epithelium 
Change in rate and depth of respiration are more likely due to anxiolytic effects 
HEPATIC SYSTEM: 
No significant effects 
HEMATOPOIETIC SYSTEM: 
Long term exposure can produce transient bone marrow depression  
Peripheral neuropathy can be produced due to its ability to inactivate vitamin B 
1213,14. 
ADVANTAGES  
  
• It has a very rapid onset because of low blood gas solubility.  
• It is a non-inflammable, non-explosive  
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• Potent analgesic 
 DISADVANTAGES 
• It is a weak anaesthetic agent with muscle relaxation effect  
• It leads to Diffusion hypoxia.  
• It causes expansion of air containing cavities  
• Megaloblastic marrow changes.  
• Demyelination of the cord leading to peripheral neuropathy.  
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MECHANISM OF ACTION OF VOLATILE ANAESTHETICS  
Though inhalational (volatile) anaesthetics has been used extensively,its 
mechanism of action is still not fully known. The inhalational anaesthetic agents 
mainly produce its effects (analgesia, amnesia, immobility) by their action on 
membrane proteins of neuronal membrane14.  
Various theories have been postulated:  
1. Meyer overton correlation:Lipid solubility_Anaesthetic potency 
2.  Critical Volume Hypothesis 
3. Modern lipid hypothesis 
4. Membrane protein hypothesis 
5. Various other mediators of Anaesthetic action 
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1. MEYER OVERTON CORRELATION: LIPID SOLUBILITY - 
ANAESTHETIC POTENCY:  
This theory suggested that potency of volatile anaesthetics depends on 
solubility in olive oil and states that lipids are the prime targets of their anaesthetic 
action.   
 The potency of the drug is directly proportional to their lipid solubility.   
                Figure 7: MEYER-OVERTON CORRELATION  
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  2.CRITICAL VOLUME HYPOTHESIS: 
  
                In 1973, Miller and Smith proposed a Lipid bilayer expansion. They 
postulated that inhalational anaesthetic molecules can accumulate inside neuronal 
lipid bilayer membrane causing  distortion and expansion . These agents reversibly 
alters the function of ion channels in membrane. The anaesthetic effect is directly 
proportional to more space within the membrane. 
Figure 8: CRICTICAL VOLUME HYPOTHESIS  
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3.MODERN LIPID HYPOTHESIS:  
  
Anaesthetic action is caused by solubilization of inhalational anaesthetic in 
lipid bilayer and lateral pressures redistribution.   
Any change in the lateral pressure shifts the conformational equilibrium of 
membrane proteins called ligand-gated ion channels.  It causes the positional and 
orientational distribution of its segments and bonds within the bilayer.   
  
Figure 9: MODERN LIPID HYPOTHESIS 
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4.MEMBRANE PROTEIN HYPOTHESIS:  
  
They found Luciferases and the other one cytochrome P450 that are two protein 
groups in cell membrane which are inactivated by inhalational anaesthetic. They 
alter functions of signalling cytoplasmic proteins that are like protein kinase C.   
They bind directly only to small number of targets in CNS mostly ligand 
(neurotransmitter) - gated ion channels - Cys-loop receptors. They are the possible 
targets of general anaesthetics that bind at the interface between the subunits.   
Figure 10: MEMEBRANE PROTEIN HYPOTHESIS  
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5 .POTENTIAL MEDIATORS OF ANAESTHETIC ACTION:  
It acts via Ionotropic(ligand gated) and Metabotropic (G protein)receptors. 
Binding of neurotransmitter(Acetylcholine) to metabotropic receptor causes 
activation of Guanosine triphosphate binding proteins (G proteins)*    associated 
with these receptors and therefore G proteins acts as secondary messenger to 
activate  other signaling molecules such as protein kinases ,potassium or 
calcium. 
  Glycine,   a major inhibitory neurotransmitter found in the spinal cord is the 
major mediator and is found responsible for immobility caused by inhalational  
anaesthetics.  
 NMDA blockade causes decrease in  Glutamate in brain. 
  TREK and TASK-3 are two pore potassium receptors that maintains the 
resting membrane potential of cell. The actions are mediated in these two 
receptors and action mediation is agent specific. TASK-3 plays a major role 
in maintaining the EEG oscillations   under general anaesthesia.  
 Voltage gated sodium channels are actually modulated rather than being 
blocked, to inhibit Glutamate release.  
 Hyperpolarisation- Activated cyclic nucleotide (HCN) gated channels in  
motor neurons are affected to produce anaesthetic immobility15.  
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PHARMACOKINETICS OF INHALED ANAESTHETICS 
  
The pharmacokinetics is the  
 Absorption or uptake  of volatile from alveoli into pulmonary capillaries  
 Distribution within the blood  
 Metabolism  in liver, kidney and  lungs 
 Elimination from lungs  
 The pharmacokinetics of inhalational anaesthetics differs in Geriatric 
population due to decreased lean body mass, impaired alveolar exchange  and 
apparent volume of distribution being in higher range.  
  CNS, the target site of action of inhalational anaesthetics depends on partial 
pressure gradient at various levels whose main aim is to achieve adequate and 
constant partial pressure in brain. 
 The alveolar partial pressure depends on arterial partial pressure which in turn 
equilibrates with partial pressure    of brain.  
 PA (Alveolar concentration )  and in  Brain PBRAIN   is important to maintain 
the optimal and constant depth of anaesthesia that  further depends on 
factors influencing delivered anaesthetic concentration.  
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DETERMINANTS OF ALVEOLAR PARTIAL PRESSURE 
 
1. TRANSFER FROM ANAESTHETIC MACHINE TO LUNG ALVEOLI:  
Inspired partial pressure 
The greater the initial inspired pressure the greater is the inhalational induction . 
After equilibration however the uptake decreases, then Pi{inspired pressure}    has to be 
adjusted according to decreased uptake.    
 Concentration effect: It states that “inspired partial pressure   
influences the alveolar partial pressure of a volatile anaesthetic ". 
 Second gas effect: This effect reflects the ability of high volume 
uptake of one gas (first gas) to accelerate the rate of increase of the PA 
of a concurrently administered companion gas(second gas). This 
principle is seen  in Nitrous oxide. Nitrous oxide auguments the 
uptake of  volatile anaesthetics and oxygen.   
  
 
 
 
 
 
 34 
 
Alveolar Ventilation:  
Increased alveolar ventilation promotes the input of inhalational 
anaesthetics to offset uptake which results in rapid increase in PA (alvbeolar) toward 
the Pi(inspired) and thus fast  induction of anaesthetics.  
a) The larger the alveolar minute ventilation is achieved, the more rapid 
the rise in alveolar concentration (FA).   
b) Hyperventilation decreases the PaCO2 which in turn will decrease 
Cerebral blood flow 
c) Greater the alveolar ventilation equalizes to FRC ratio, more rapid is 
the rate of   increase of PA.  
 Spontaneous and mechanical ventilation: When a high Pi is administered, 
Inhalational anaesthetics influence their own uptake by dose-dependent 
effects on alveolar ventilation and it acts as protective negative feedback 
mechanism. This phenomenon seen with patient on spontaneous breathing.  
  
 Impact of solubility: Changes in the alveolar ventilation influence the rate 
of increase of PA of soluble anaesthetics (halothane, isoflurane) more than a 
poorly soluble anaesthetics (nitrous oxide, desflurane ,sevoflurane).  
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Anaesthetic Circuit:   
three important determinants,  
a) Gas inflow from the anaesthetic machine 
b)  Volume of the breathing circuit. 
                        Volume of the circuits slows the attainment of PA. This can be 
eliminated by using higher flow rates. 
c) Solubility of the agent: Solubility of the agent slows the rate at  
     which PA increases, and    also the rate at which the PA decreases 
2. SOLUBILITY:  
Partition coefficients reflects the capacity of each phase to accept the 
anaesthetic agent.  
• Blood:Gas partition coefficients:  
 The solubility is inversely related to the rate of rise of PA.  
 Higher the blood: gas partition coefficient, larger the amount of 
anaesthetic must be dissolved in the blood before equilibration.  
 Increasing the Pi above the required can increase the rate of 
induction. This is called overpressure.  
 The rapid increase of PA  associated with Nitrous oxide also causes 
absorption of several litres of nitrous oxide leads to expansion of air-
containing spaces  
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Blood: gas partition coefficients is altered by variations in water,lipid  
and protein content and hematocrit of whole blood. The solubility of  
volatile anaesthetics varies with extremes of age14,16,17.  
 
Table 1: BLOOD: GAS PARTITION COEFFICIENT  
Anaesthetic agent  Blood: gas coefficient at 37 
degree C  
Desflurane  
  
0.42  
Sevoflurane  
  
0.69  
Nitrous oxide  
  
0.46  
  
• Tissue: Blood partition coefficient:  
 This determines the uptake of anaesthetic into the tissues.  
 For equilibration between blood and the brain it take three time constant for 
95% of change to occur14,16,17.  
Table 2: BRAIN: BLOOD PARTITION COEFFICIENT  
  
Anaesthetic agent  
Brain :blood  Time constant  Equilibrium  
  
Desflurane  
  
1.3  3.1  9.3  
  
Sevoflurane  
  
1.7  2.4  7.1  
  
Nitrous oxide  
  
1.1  2  6  
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Oil: Gas partition coefficient:  
 This parallels the anaesthetic requirement and determines the potency of the 
drug.  
MAC can be calculated as 150 divided by the oil: gas coefficient.  
3. Cardiac Output CO:  
 Cardiac output influences uptake by carrying away either more or less 
anaesthetic.  
 Increased cardiac output results in rapid uptake, so rate of increase in PA is 
slowed and thus slower induction.  
 Conversely, rate of rise of poorly soluble drugs like Nitrous oxide is rapid 
regardless of the physiological variations in cardiac output.  
 Volatile anaesthetics that depress cardiac output exerts a positive feedback.  
• Shunt:  
 It is valid to assume that arterial and alveolar partial pressure to be identical in 
the absence of an intracardiac shunt.  
 In the presence of the shunt, the diluting effect of the shunted blood will delay 
the induction process.  
  Impact of the right to left shunts on the rate of increase in the arterial blood 
depends on the solubility of the anaesthetic.  
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 Right to left shunt decreases the rate of rise of Pa of poorly soluble anaesthetic.  
 Left to right shunts results in delivery of blood with high partial pressures to 
the lungs. The effect of left to right shunt offsets the dilutional effects of right 
to left shunts.   
• Alveoli to Venous Pressure Difference 
 This represents tissue uptake of the inhaled agent.  
 The same factors which influence the uptake by the blood from the lungs also 
influences the uptake by the tissues from the blood.  
 There is initially a rapid uptake of agents in the vessel-rich group, however after 
three time constants, there is a significant decrease in the tissue uptake reflecting 
the narrow inspired to alveolar partial pressure difference.  
 vessel rich group VRG - brain, heart, kidney & liver  
 the muscle group MG - muscle & skin  
 the fat group FG - large capacity/minimal flow  
 vessel poor group VPG - bone, cartilage & CT  
  
4. METABOLISM:  
Inhaled anaesthetics  leave the body unchanged through the lungs.   
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Recovery from an inhalational anesthetic   
 It is the reverse process of the anaesthetic induction:   
a) The rate of fall in brain concentration should be rapid for a agents that are not highly 
soluble in brain44 P BRAIN .   
b) Return of consciousness occurs when the PBRAIN drops below MAC-Awake 
c) Even after prolonged anaesthetic, skeletal muscles probably and fat almost certainly 
will not have equilibrated with the PA of the anaesthetic.  
d) Recovery is prolonged in proportion to the duration of surgery for soluble 
anaesthetics.  
e) Anaesthetic absorbed into the components of the breathing system will retard the rate 
of decrease in the PA of the anaesthetics17,18. 
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 MINIMAL ALVEOLAR CONCENTRATION(MAC): 
MAC of inhalational anaesthetics is defined as  concentration at 1 atmosphere that 
prevents skeletal muscle movements in response to supramaximal painful 
stimulus(surgical skin incision ) in 50% of patients10. 
MAC is an anaesthetics 50% Effective dose(ED 50%) 
MAC awake : 
It is the concentration of anaesthetics that prevents consciousness in 50% of 
patients, is reliably about half of MAC. 
MAC memory: 
It is the concentration of anaesthetics that is associated with amnesia in 50% of 
patients and it is significantly less than MAC awake. 
MAC bar: 
It is the concentration of anaesthesia that blocks autonomic response to surgical 
incision in 50% of patients. 
MAC intubation:  MAC that would inhibit movement and coughing during endotracheal 
intubation18,19. 
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FACTORS  AFFECTING MAC: 
Increase in MAC: 
 Hyperthermia 
 Hypernatremia 
 Drugs increasing catecholamine secretion 
 Cyclosporine 
Decrease in MAC: 
 Hypothermia 
 Increasing age 
 Drugs decreasing catecholamines secretion. 
 Acute alcohol ingestion 
 Alpha 2 agonist 
  Neuraxial opioids 
 Hyponatremia 
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No change in MAC: 
 Chronic alcohol abuse 
 Gender 
 Duration of anaesthesia 
 Thyroid gland dysfunction 
 Hyperkalemia or Hypokalemia18,19 
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LARYNGEAL MASK AIRWAY 
DR.ARCHIE BRAIN discovered LMA in 1983 And in clinical use since 1988 
and its playing its important role since then. 
Miller classification of LMA : 
CUFFED PERILARYNGEAL SEALERS: 
                        Nondirectional sealers:LMA,ILMA,Soft seal ..etc 
                        Directional sealers:PLMA 
CUFFED PHARYNGEAL SEALERS: 
                         Without oesophageal sealing:COPA, PAX 
                         With oesophageal sealing:Combitube, LT, LTS,Proseal LMA. 
CUFFLESS preshaped sealers: 
                         SLIPA, I_gel, Baska mask.  
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Proseal LMA types according to weight of the patients. 
TABLE 3:PROSEAL LMA SIZE ACCORDING TO WEIGHT 
PROSEAL LMA         
SIZE 
WEIGHT OF 
THE PATIENT 
MAXIMUM 
CUFF 
INFLATION (in 
ml) 
2 ½ 20 to 30 14 
3 30 to 50 20 
4 50 to 70 30 
 
Advantages of LMA: 
 Less Sympathetic stimulation thereby decreasing stress response 
associated  with ET tube. 
  LMA is well tolerated at lighter plane of anaesthesia and do not 
require  any muscle relaxation. 
 Incidence of sore throat and other  complications associated with 
intubation are lesser with LMA. 
 It is a rescue device in “can’t intubate can’t ventilate situation .” 
  It is used to maintain airway during short elective surgical 
procedures 
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Disadvantages: 
 It is not a definitive Airway. 
 It is not recommended in full stomach patients and patients with reflux disease as it 
increases the chance of aspiration .However this problem is less common with second 
generation SAD as it has a  separate gastric port for gastric contents20. 
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MATERIALS AND METHODS  
  
SOURCE AND SIZE OF SAMPLE: 
This study was done on 60 patients undergoing Fibroadenoma excision in The 
Department of General surgery, Stanley Medical College, Chennai. Based on pilot 
study sample size was calculated.  
INPUT: 
Tail(s)  =    2 
Effect size d =    0.74  
 Alpha error prob =    0.05 
Power (1-beta error prob)  =    0.80  
Allocation ratio N2/N1   =    1 
Noncentrality parameter delta =   2.8660077 
Critical t  =   2.0017175 
Df  =    58 
Sample size Group 1  =    30 
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Sample size Group 2  =     30 
Total sample size   =     60 
Actual power        =    0.8046348 
 
STUDY DESIGN: 
Approval of the Institutional ethical committee was obtained. Randomisation 
was done by computerized method . It was a prospective comparative single blinded 
study. 
The study was conducted on 60 patients over a period of eight months. Patients 
were explained about the procedure in detail and informed written consent was 
obtained. 
Inclusion criteria:      
 Age 18-50 years 
 ASA PS I and II 
 Fibroadenoma excision 
 Surgery lasting less than one hour 
 Under general anaesthesia 
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Exclusion criteria:  Patients with  
Age <18 or >50 years 
 Obese patients [BMI] 
 Uncontrolled diabetes or hypertension. 
 MPC 3 and 4 
 MATERIALS:  
   The following equipments, drugs and monitors were kept ready for the conduct of 
anaesthesia.    
EQUIPMENTS:  
  
 Anaesthesia work station with ventilator  
 Laryngeal mask airway Proseal of size 3,4,5. 
  
 Laryngoscope with all sizes of blades.   
 Endotracheal Tubes - 6 mm ID to 7.5 mm ID.   
 Oropharyngeal airways   
 Oxygen source   
 Suction Apparatus  
 Desflurane vaporiser  
 Sevoflurane vaporiser  
 End-tidal carbon dioxide analyser  
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 Anaesthesia agent gas monitor  
 Oxygen analyser 
 Bain”s circuit  
 Ambu bag 
 
 DRUGS:  
 Inj. Glycopyrrolate  
 Inj. Fentanyl  
 Inj. Propofol  
 Inj. Ondansetron  
 Desflurane  
 Sevoflurane  
 
Emergency drugs:  
 Inj. Atropine  
 Inj. Ephedrine  
 Inj. Adrenaline  
 Inj. Frusemide  
 Inj. Hydrocortisone  
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 Inj. Nitroglycerine  
 Inj. Dopamine  
 Inj. Dexamethasone 
 
MONITORS:  
  ECG   
 Pulse oximeter  
 Non-invasive blood pressure   
 End -tidal carbon dioxide  
 Oxygen analyser  
 Anaesthesia gas monitors for Nitrous oxide, Desflurane and  Sevoflurane  
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METHODOLOGY 
Pre-anaesthetic assessment was performed and detailed history has been recorded and 
complete physical assessment was done. Complete blood count, renal function test, 
blood grouping/typing, random blood sugar, electrocardiograph and chest x-ray were 
done. Patients not fulfilling the inclusion  criteria were excluded from the study.  
                      60 patients in the age group of 18-50 years, ASA PS I-II were 
randomised    by using computerized randomization into 2 groups of 30 each. 
GROUP D [Desflurane](n=30) 
GROUP S [Sevoflurane] (n=30) 
            In both the groups patients were asked to fast for 8 hours and  nil per oral 
status was confirmed on the morning of surgery. 18G peripheral venous cannula was 
inserted and intravenous fluids were administered. All   monitors were attached. 
            Premedication: Inj.glycopyrrolate 0.2mg iv, Inj.fentanyl 1.5mcg/kg iv 
,Inj.ondansetron 0.1mg/kg iv given.  
           Preoxygenation: done with 100% O2 for 3 mins with  6 litres per min.           
           Induction: Inj. propofol 2.5mg/kg iv and loss of motor response to Jaw thrust 
was noted and taken as end point for LMA insertion  and airway was secured using  
Proseal  LMA ,size chosen according to weight of patient  and connected to close 
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circuit  and maintained on Spontaneous ventilation throughout the procedure22,23. 
• GROUP D: Patients assigned to Desflurane groups  received Desflurane with 
nitrous oxide and oxygen mixture in the ratio of 66:33%. Initially  flow rates of 
Nitrous oxide and oxygen were kept at  4:2 litres  and dial concentration of Desflurane 
at   6%. When endtidal concentration of 4% of Desflurane was achieved,  flow rate of 
nitrous oxide:oxygen was reduced to 2:1 litres and dial concentration titrated between 
3.5% to 4.5% so that end tidal concentration of Desflurane  was maintained at 4%19. 
 
• GROUP S: Patients assigned to Sevoflurane groups received Sevoflurane with 
nitrous oxide and oxygen in ratio of 66:33%. Initially  flow rate  of Nitrous 
oxide:oxygen was kept at  4:2 litres  and dial concentration of Sevoflurane at  2.5%.  
                 When end tidal concentration of sevoflurane of 1.2% was achieved, flow 
rates  of Nitrous oxide:oxygen was reduced to 2:1 litres and dial concentration titrated 
between 0.8% and 1.4% so that end tidal was maintained at 1.2%19 . 
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       Following parameters were monitored and documented throughout the procedure: 
 
 The Heart rate ,rhythm and Mean arterial pressure and SPO 2   was continuously 
monitored at  pre induction, post induction, after LMA insertion and at skin 
incision and at 2 minutes ,5 minutes after that and every 5 minutes till the end 
of surgery and at 15th minute postoperatively.   
 Patients depth and adequacy of spontaneous respiration was monitored by 
EtCO2 , which was maintained between 25 to 35. Once the exhaled volatile 
anaesthetic concentration was equal to the inhaled concentration and 
when no further changes were seen, the fresh gas flows were reduced to 
Nitrous oxide: Oxygen in the ratio of 2:1 l/min21,23. 
 Volatile anaesthetic concentration were adjusted to maintain a exhaled 
concentration of 4% in Desflurane group and 1.2% in Sevoflurane group. Any 
decrease in blood pressure with a MAP <60 mmHg was managed with 100ml 
bolus fluid administration and Ephedrine 6mg i.v bolus2.  
 Primary inhaled anaesthetic agent was maintained at the desired concentration  
throughout the procedure  and was discontinued at the end of last skin suture 
which was taken as TIME 0. 
 From time 0(zero), Time taken for all other parameters were noted. 
 Nitrous oxide was discontinued after thorough oral suctioning. 
  Time taken to achieve response to Painful stimulus (Response to pressing of 
knuckles over sternal notch),Verbal commands 
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(Eye opening response to call of their names)  and Spontaneous eye 
opening were noted as emergence parameters2,5. 
 LMA removed after spontaneous eye opening and after observing gag 
reflex22,23. 
 Patient were observed for time taken to recall of name and time taken to 
achieve Post Anaesthesia Recovery Score OF Aldrete and  Kroulik  >10 (PARS 
>10), and time taken for LMA removal since time 0. These parameters were 
noted as recovery parameters. 
 Airway adverse effects such as cough, breath holding (apnoeic spells), 
laryngospasm, desaturation , post operative nausea and vomiting were noted2,5. 
 Patients were observed for immediate post op complications (<30minutes) like 
nausea, vomiting, pain. 
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POST ANAESTHESIA RECOVERY SCORE OF ALDRETE AND KROULIK  
(PARS)13 
 
1.Consciousness Score 
                               Easily arousable, alert 3 
                               Arousable, oriented, not alert 2 
                               Arousable, not oriented 1 
                              Not responding 0 
    
2. Ventilation 
                            Normal 2 
                            Not perfect but requires no support 1 
                            Airway requires support 0 
    
3.Circulation:Difference in mean Arterial pressure from baseline 
                                        <10% 2 
                                      10-20% 1 
                                            >20% 0 
    
4.Respiratory stability 
                        Able to breathe deeply 2 
                        Tachypnoea with good cough 1 
                        Dyspnoeic with weak cough 0 
    
5.Count down test( backward from 10 to 0) 
                                  Succeed right away 2 
                                Succeed in 30 secs                                                                                                                 1
                                Fail in 30 secs 0 
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AIRWAY ADVERSE EFFECTS SCORE [Veg N,Wall described scale]24 
1. COUGH: 
                    No cough                                                                                 0 
                    1 or 2 cough with SPO2 >95%                                            1 
                    3 multiple cough with SPO2 <95%                                    2 
                    4 multiple cough with SPO2 <95% with IV                     3 
                                                 medication required 
2.BREATH HOLDING:(APNOEIC SPELLS) 
                   No breath holding                                                            0 
                   No breath holding occurred for 10-20 seconds               1 
                   No breath holding occurred for 20-30 seconds               2 
                   Breath holding occurred exceeding 30 seconds                3 
3.LARYNGOSPASM: 
                    No evidence of stridor or phonation                              0 
                     If evidence of stridor or phonation occurs 
                    <15 seconds or no therapy other than ppv                1 
                     If evidence of stridor or phonation occurs 
                    >15 seconds                                                      2  
                  If evidence of stridor or phonation occurs  
                          >15 seconds requiring IV medication                     3  
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OBSERVATION AND RESULTS 
 
The collected data were analysed with IBM.SPSS statistics software 23.0 
Version to describe about the data descriptive statistics frequency analysis, percentage 
analysis were used for categorical variables and the mean & S.D were used for 
continuous variables. To find the significant difference between the bivariate samples 
in Independent groups the Unpaired sample t-test was used. To find the significance in 
categorical data Chi-Square test was used. In both the above statistical tools the 
probability value 0.05 is considered as significant level.  
           P - Value ** Highly Significant at P ≤ .01     
           P - Value * Significant at 0.01 < P ≤ .05     
       
 P -Value # No Significant at P >.05   
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AGE DISTRIBUTION:  
 Table 4: AGE DISTRIBUTION  
GROUP  
 
 
MEAN  
(Years) 
STD.  
DEVIATION  
  
 
STD. ERROR  
MEAN  
  
 
 
p  
VALUE  
Desflurane  
Sevoflurane  
25.50 
26.10  
5.661  
5.548  
1.034  
1.013  
0.438 (NIL       
SIGNIFICANCE) 
  
The mean age of patients was 25.50 years in Desflurane group and 26.10 years in 
Sevoflurane group. The p-value was 0.438 which was not significant. The two groups 
were standardized with respect to age of patients.  
FIGURE:11 AGE DISTRIBUTION 
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WEIGHT DISTRIBUTION:  
Table 5: WEIGHT DISTRIBUTION  
GROUP  MEAN(kg)  
STD.  
DEVIATION  
STD  
ERROR  
P VALUE  
Desflurane  
Sevoflurane  
59.76  
57.82  
6.702  
5.985  
0.948 
0.846  
0.130  
(NIL 
SIGNIFICANCE) 
  
The mean weight of patients in Desflurane group was 59.76 kg and in Sevoflurane 
group it was 57.82 kg. The two groups were standardized with respect to weight .        
Figure12:WEIGHT DISTRIBUTION 
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ASA PS DISTRIBUTION  
24 patients in Desflurane group and 27 patients in Sevoflurane group belonged to 
ASA PSI status and 6 patients in Desflurane group and 3 patients in Sevoflurane 
group belonged to ASA PS II status. ASA PS status was standardized between two 
groups as p value was 0.779 which was not significant.  
Table 6: ASA PS DISTRIBUTION  
  American 
society of 
anaesthesiologist 
:Physical status  
                     GROUP  
TOTAL  
Desflurane  Sevoflurane  
  I   24 27 51  
 
%within group  80.0%  90.0%  85.0%  
 
II   6 3 9  
 
% within group  20.0%  10.0%  15.0%  
Total   30  30  60  
  
% within group  
  
100.0%  
  
100.0%  
  
100.0%(NIL 
SIGNIFICANCE)  
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Figure13:ASA PS DISTRIBUTION 
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TIME TAKEN TO ACHIEVE DESIRED END TIDAL CONCENTRATION. 
 
TABLE 7: TIME TAKEN TO ACHIEVE DESIRED END TIDAL 
CONCENTRATION. 
DESIRED END TIDAL 
CONCENTRATION 
MEAN TIME TAKEN 
(MINUTES) 
P VALUE 
4% DESFLURANE 3.431 0.156 
(NOT 
SIGNIFICANT) 
1.2% SEVOFLURANE 4.09 
 
In group D the  mean time taken to achieve 4% Desflurane end tidal concentration  
was 3.431minutes. 
In group S the mean time taken to achieve 1.2% sevoflurane end tidal  concentration 
was 4.09 minutes. 
On statistical analysis, p value was 0.156 which is not significant. Hence the two 
groups were comparable. 
 
 
 
 
  
63 
FIGURE 14: TIME TAKEN TO ACHIEVE DESIRED END TIDAL 
CONCENTRATION. 
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TOTAL DURATION OF SURGERY (minutes)  
 
Table 8: TOTAL DURATION OF SURGERY (minutes)  
  
GROUP  MEAN 
(minutes)  
STD  
DEVIATION  
STD 
ERROR  
P  VALUE  
 Desflurane  40.70 5.5965  1.0218   0.207  
(NIL 
SIGNIFICANCE) 
 
Sevoflurane  38.77  6.5028  1.1872     
 
The mean  total duration of surgery in Desflurane group was 40.70 minutes and in the 
Sevoflurane group it was 38.70 minutes. On analysing this, the p value was 0.207 
which was not significant. Hence the two groups were comparable with respect to 
duration of surgery   . 
FIGURE 15: TOTAL DURATION OF SURGERY  
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 TOTAL DURATION OF ANAESTHESIA (minutes)  
  
 Table 9: TOTAL DURATION OF ANAESTHESIA  
  
GROUP  MEAN 
(minutes)  
STD  
DEVIATION  
STD  
ERROR  
P VALUE 
Desflurane    
  
Sevoflurane  
  
48.67 
  
45.55  
  
5.9904 
  
10.8449  
  
1.0937  
  
1.9800  
  
0.174 
 
(NIL 
SIGNIFICANCE) 
  
The mean total duration of anaesthesia in Desflurane group was 48.667 minutes and in 
the Sevoflurane group it was 45.552 minutes. On analysing this, the p value was 0.174 
which was not significant and were comparable in both the groups.    
  
 
Figure 15: TOTAL DURATION OF ANAESTHESIA  
1 
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TIME TAKEN FOR DISCONTINUATION OF NITROUS OXIDE (minutes)  
 
 Table 10:  TIME TAKEN FOR DISCONTINUATION OF NITROUS OXIDE:  
  
GROUP  MEAN 
(minutes)  
STD 
DEVIATION  
STD 
ERROR  
P  
VALUE  
  Desflurane  4.53  1.167  0.213 0.581  
  Sevoflurane  
  
4.37  
  
1.159  
  
0.212  
  
(NIL 
SIGNIFICANCE) 
     
The mean duration of discontinuation of Nitrous oxide following discontinuation of 
the primary anaesthetic agent was 4.53 minutes in Desflurane group and 4.37 minutes 
in Sevoflurane group which is statistically significant as p value was  0.581 
 
FIGURE 17:TIME TAKEN FOR DISCONTINUATION OF NITROUS OXIDE                  
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TIME TAKEN FOR RESPONSE TO PAINFUL STIMULUS: 
Table 11: TIME TAKEN FOR RESPONSE TO PAINFUL STIMULUS (minutes) 
 GROUP  MEAN 
(minutes)  
STD 
DEVIATION  
STD 
ERROR  
P  
VALUE  
Desflurane  6.37 1.303  0.238  0.02  
Sevoflurane  7.90  1.129 0.206   
(SIGNIFICANCT) 
  
The mean time taken for the patient to respond to painful stimulus following 
discontinuation of primary inhalational agent  was 6.37 minutes and 7.90 minutes in 
Desflurane and Sevoflurane group respectively. On statistically analyzing the data, p 
value was 0.02, hence statistically significant. The time taken for the response to 
painful stimuli was longer with sevoflurane when compared with Desflurane. 
Figure 18:  TIME TAKEN FOR RESPONSE TO PAINFUL STIMULUS 
 
  
 
68 
RESPONSE TO VERBAL COMMANDS (minutes)  
  
Table 12: TIME TAKEN FOR RESPONSE TO VERBAL COMMANDS  
GROUP  MEAN 
(minutes)  
STD 
DEVIATION  
STD 
ERROR  
P  
VALUE  
  Desflurane  8.30 1.022  0.187  0.003  
Sevoflurane  9.67  0.844  0.154  (SIGNIFICANT) 
  
The mean time taken to respond to vocal commands was 8.30 minutes and 9.67 
minutes in Desflurane and Sevoflurane group. The difference was statistically 
significant with Sevoflurane group taking longer time to respond to verbal commands.  
 Figure 19: TIME TAKEN FOR RESPONSE TO VERBAL COMMANDS  
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SPONTANEOUS EYE OPENING (minutes)  
  
Table 13: TIME TAKEN FOR SPONTANEOUS EYE OPENING  
  
GROUP  MEAN 
(minutes)  
STD 
DEVIATION  
STD 
ERROR  
P value  
   Desflurane  9.03 1.221 0.223  0.028  
         Sevoflurane  10.10  1.185  0.216  (SIGNIFICANT) 
  
  
There exist a  statistical significant difference with the time taken for spontaneous eye 
opening in both the groups with a mean duration of 9.03 minutes in Desflurane group 
and 10.10 minutes in Sevoflurane group. The p value was 0.028. 
Figure 20: TIME TAKEN FOR SPONTANEOUS EYE OPENING  
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 LMA REMOVAL (minutes)  
 Table 14: TIME TAKEN FOR LMA REMOVAL AFTER VOLATILE 
DISCONTINUATION (minutes) 
  
GROUP  MEAN  
(minutes) 
STD  
DEVIATION  
STD  
ERROR  
P  
VALUE  
  Desflurane  9.3  1.194  0.218  0.034  
           Sevoflurane  10.10  1.185  0.216  
  
The time taken for LMA removal in Sevoflurane group was significantly longer when 
compared to the Desflurane group with a mean time taken for LMA removal being 
9.30 minutes and 10.10 minutes in Desflurane and Sevoflurane group respectively.  
FIGURE 21: TIME TAKEN FOR LMA REMOVAL AFTER VOLATILE 
DISCONTINUATION 
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 RECALL OF NAME (minutes)  
Table 15: TIME TAKEN FOR RECALL OF NAME (minutes) 
  
GROUP  MEAN  
(minutes) 
STD 
DEVIATION  
STD 
ERROR  
P  
VALUE  
 Desflurane  
      Sevoflurane  
10.22  
12.38  
1.148  
1.338  
0.162  
0.189  
0.000 
(SIGNIFICANT)  
 `` 
The mean time taken to recall their name was prolonged in Sevoflurane group with the 
duration of 12.38 minutes when compared to Desflurane group  which was 10.22 
minutes which  was statistically significant.  
FIGURE 22:TIME TAKEN FOR RECALL OF NAME 
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TIME TAKEN  FOR POST ANAESTHESIA RECOVERY SCORE OF 
ALDRETE AND KROULIK(PARS)*>10 
 Table 16: TIME TAKEN FOR POST- ANAETHESIA RECOVERY  
SCORE >10 (MINUTES) 
 
GROUPS MEAN 
(minutes) 
STANDARD 
DEVIATION 
STANDARD 
ERROR 
MEAN 
DESFLURANE 
SEVOFLURANE 
11.37 
12.87 
1.671 
1,456 
0.305 
0.266 
0.000 
(SIGNIFICANT) 
 
The time taken for  post anaesthesia recovery score of Aldrete and kroulik(PARS) 
score to attain more than 10  was 11.37 minutes and 12.87 minutes in Desflurane and 
Sevoflurane group respectively. On statistical analysis, the difference was significant, 
with Desflurane being faster when  compared to Sevoflurane.  
Figure 23: TIME TAKEN FOR POST- ANAETHESIA RECOVERY 
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ADVERSE AIRWAY EFFECTS 
 
                      TABLE 17: TABLE FOR  ADVERSE AIRWAY EVENTS 
 
ADVERSE EFFECTS GROUP D(n=30) GROUP S(n=30) 
COUGH 9 1 
LARYNGOSPASM 0 0 
APNOEIC SPELLS 0 0 
NAUSEA & VOMITING 0 0 
OTHERS 0 0 
 
 
AIRWAY ADVERSE 
EFFECTS 
GROUPS 
Total DESFLURANE SEVOFLURANE 
COUGH Count 9 1 10 
% within 
GROUPS 
30.0% 3.3% 16.7% 
LARYNGSPASM Count 0 0 0 
% within 
GROUPS 
0.0% 0.0% 0.0% 
BREATH 
HOLDING  
Count 0 0 0 
% within 
GROUPS 
0.0% 0.0% 0.0% 
NAUSEA AND 
VOMITING 
Count 0 0 0 
% within 
GROUPS 
0.0% 0.0% 0.0% 
Total Count 9 1 10 
% within 
GROUPS 
30% 3.3% 16.7% 
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FIGURE 24:AIRWAY ADVERSE EVENTS 
 
     
 
 
 
 
 
Cough of grade 1 was noted in 9 patients in desflurane group and in 1 patient in 
sevoflurane group. On statistical analysis p value was 0.04 and hence significant. 
Other adverse airway events like laryngospasm, apnoeic spells, nausea and vomiting 
were not noted in both the groups hence they are comparable. 
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Table 19: INTRA-OPERATIVE HERAT RATE   
  
 
 
 
 GROUP MEAN p VALUE 
PRE 
INDUCTION 
DESFLURANE 
SEVOFLURANE 
85.53 
82.56 
0.05 
POST 
INDUCTION 
DESFLURANE 
SEVOFLURANE 
79.93 
76.9 
 
0.06 
POST LMA 
INSERTION 
DESFLURANE 
SEVOFLURANE 
94.4 
90.50 
0.05 
SKIN 
INCISION 
DESFLURANE 
SEVOFLURANE 
82.36 
80.4 
0.06 
5 MINUTES DESFLURANE 
SEVOFLURANE 
86.4 
83.8 
0.06 
10 MINUTES DESFLURANE 
SEVOFLURANE 
83.86 
81.06 
0.07 
15 MINUTES DESFLURANE 
SEVOFLURANE 
82.4 
79.6 
0.05 
30 MINUTES DESFLURANE 
SEVOFLURANE 
80.6 
78.16 
0.06 
45 MINUTES DESFLURANE 
SEVOFLURANE 
79.7 
76.96 
0.05 
60 MINUTES DESFLURANE 
SEVOFLURANE 
91.06 
88 
0.06 
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FIGURE 26: INTRA OPERATIVE HEART RATE RANGE 
 
 
  
In both the groups, there was fall in heart rate post induction by 15% of baseline 
value.  Post LMA insertion there was increase in heart rate by 10% of baseline value. 
On statistical analysis, p value was 0.06 which is not significant and hence heart rates 
were  comparable between both the groups. 
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INTRA-OPERATIVE MEAN ARTERIAL PRESSURE: 
Table 20: INTRA-OPERATIVE MEAN ARTERIAL PRESSURE 
TIME GROUP MEAN(mmhg) p value 
PRE INDUCTION DESFLURANE 
SEVOFLURANE 
84 
84 
 
0.23 
POST INDUCTION DESFLURANE 
SEVOFLURANE 
68 
70 
0.27 
POST LMA 
INSERTION 
DESFLURANE 
SEVOFLURANE 
94 
94 
0.31 
SKIN INCISION DESFLURANE 
SEVOFLURANE 
81 
82 
0.25 
5 MINUTES DESFLURANE 
SEVOFLURANE 
77 
77 
0.6 
15 MINUTES DESFLURANE 
SEVOFLURANE 
74 
73 
0.27 
30 MINUTES DESFLURANE 
SEVOFLURANE 
68 
68 
0.23 
45 MINUTES DESFLURANE 
SEVOFLURANE 
73 
74 
0.12 
45 MINUTES DESFLURANE 
SEVOFLURANE 
91 
92 
0.07 
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In both the groups, there was fall of mean arterial pressure post induction by 15% of 
baseline value and post LMA insertion there was increase in mean arterial pressure by 
10% of baseline value.  On statistical analysis p value was  not significant and hence 
mean arterial pressure measurements were comparable between both the groups. 
The haemodynamic changes were comparable between both the groups. 
 
 
 
 
                                                     
 Figure 27: INTRA-OPERATIVE MEAN ARTERIAL PRESSURE 
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DISCUSSION  
  
    
   Fibroadenoma is a benign  superficial tumour  in the breast commonly found 
in younger age groups under 30.The benign tumour consists of  breast tissue and 
stromal or  connective tissue with or without calcification.It may be single or multiple. 
Fibroadenoma excision being a superficial surgery it does not require muscle 
relaxation and at the same time it warrants rapid emergence from anesthesia as it is a 
short surgical procedure. Management of early recovery without any airway adverse 
effects and hemodynamic instability is the most important part of a standardized 
balanced general   anaesthesia technique25.   
The newer inhalational anaesthetics allow rapid emergence from anaesthesia 
because of easy titratability  and their low blood: gas partition coefficient. To avoid 
deep airway manipulation and to avoid muscle relaxation which this surgery does not 
require, we decided to allow patients in spontaneous respiration throughout the 
procedure. Therefore we decided to administer General anaesthesia via Proseal LMA 
with patient in  spontaneous ventilation throughout the procedure. 
Hence, this study was planned to compare the emergence, recovery profile and 
Airway adverse effects of Desflurane and Sevoflurane as primary objective  and  
heamodynamic variations as secondary objective. The study was a prospective, 
randomized comparative observational study.  
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In our study the sample size was calculated as 60 with a power of 95% and a 
significance level of 0.05.  
60 female patients undergoing Fibroadenoma surgery between the age of 18 
and 50 were selected, since the minimum alveolar concentration of the volatile 
anaesthetics differs in extremes of age. This study was conducted via a closed circuit 
as JY Park et al study showed Closed circuit  mode allowed a faster and more 
reliable induction, lower inhalational anaesthetic consumption and stable 
haemodynamic and recovery profiles. Patients were included and excluded as per the 
inclusion and exclusion criteria12.  
On analysing the demographic profile, the distribution of age and  weight  of 
the patients in both the groups were comparable. Also, there was no significant 
difference in the ASA PS status and  duration of  anaesthesia and surgical duration 
between the two groups.The time taken to achieve desired endtidal concentration  was 
comparable in both the groups.This was similar to S.cregin et al study2. 
  
We observed  emergence, recovery and airway adverse effects as our primary  
objectives.The time taken for response to painful stimulus and response to verbal 
commands and  spontaneous eye opening as emergence parameters . In my study the 
emergence parameters were faster in Desflurane group  when compared with 
Sevoflurane group.  
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The time taken to recall of name, time taken for  LMA removal and time taken 
to achieve  PARS score >10  were considered as recovery parameters.  
The mean duration of time taken for response to painful stimulus  was 7.90 
minutes in Sevoflurane group and 6.37 minutes in Desflurane group. The mean time 
of time taken for response to verbal stimulus was 9.67 minutes in Sevoflurane group 
and 8.30 minutes in Desflurane group. The mean duration of time taken for 
spontaneous eye opening  was 9.03 minutes in Sevoflurane group and 10.10 minutes 
in Desflurane group.  This was similar to the  S Gergin et al study which showed a 
faster emergence in Desflurane group2.  
 
Recovery parameters such as Time taken for LMA removal, Recall of name 
and time taken to achieve PARS score >10 were faster in Desflurane group in 
comparison with Sevoflurane group and this was statistically significant(p<0.05).  
The mean duration of time taken for response LMA removal  was 10.10minutes 
in Sevoflurane group and 9.3 minutes in Desflurane group. The mean  time taken for 
recall of names was 12.38 minutes in Sevoflurane group and 10.22 minutes in 
Desflurane group.  This was similar to the  S Gergin et al study which showed a 
faster recovery in Desflurane group. 
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Nathanson MH et al also concluded in his study which he performed on 42 
women undergoing laproscopic sterilization to compare emergence and recovery of 
Desflurane and sevoflurane that Desflurane had faster emergence when compared to 
sevoflurane5.McKay RE et al concluded in their study that the time taken to response 
to verbal commands was significantly longer with sevoflurane when compared to 
Desflurane6.  
 The mean duration for PARS >10 was 11.37 minutes and 12.87 minutes in 
Desflurane and Sevoflurane group respectively. This was similar to Isik y et al study 
which concluded PARS >10 was significantly rapid in and its 11 minutes and 12.5 
minutes in Desflurane group and Sevoflurane group9.  
L. E. C. De Baerdemaeker et al conducted a study  regarding optimization of 
Desflurane and Sevoflurane doses in morbidly obese patients using a inhalational 
bolus technique. In this study they concluded Immediate recovery was significantly 
faster in the Desflurane group.  Similar results were obtained in my study. 
 Airway adverse effects like cough ,laryngospasm, breath holding are noted. In 
my study in 9 patients in Desflurane group had  bout of cough with SPO2 >95% and 
only one patient in Sevoflurane group had one bout of cough and this was statistically 
significant(p<0.05).Other airway adverse effects were not noted among both groups.     
White PF Tang J et al  concluded that Desflurane had high incidence of cough 
during recovery when compared to Sevoflurane .KLOCK PA Czeslick et al  also  
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concluded that desflurane has more incidence of cough at 1MAC which was similar to 
our study. 
 Haemodynamic variations SUCH AS Heart rate variability and mean arterial pressure 
were secondary objectives. both the groups, there was fall in heart rate post induction 
by 15% of baseline value.  Post LMA insertion there was increase in heart rate by 10% 
of baseline value. On statistical analysis, p value was 0.06 which is not significant and 
hence heart rates were  comparable between both the groups. 
                            In both the groups, there was fall of mean arterial pressure post 
induction by 15% of baseline value and post LMA insertion there was increase in 
mean arterial pressure by 10% of baseline value.  On statistical analysis p value was  
not significant and hence mean arterial pressure measurements were comparable 
between both the groups. Haemodynamic variations were comparable  between both 
Desflurane and Sevoflurane groups. 
Several studies found no significant difference in haemodynamic changes 
between Desflurane and Sevoflurane. 
The occurrence of immediate postoperative nausea and vomiting (PONV) was 
noted for 30 minutes. No significant differences were detected in nausea and 
vomiting. Our study agreed with the Alex Macario et al study which also found that 
there was no significant occurrence of nausea and vomiting25.   
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CONCLUSION: 
In this randomized comparative study between Desflurane and sevoflurane for 
Fibroadenoma excision under general anaesthesia with spontaneous respiration , I 
conclude that  Desflurane had  rapid emergence and recovery when compared with 
sevoflurane. However the incidence of cough was significantly higher in Desflurane. 
Haemodynamic parameters and other adverse airway affects are comparable in both 
the groups. 
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PROFORMA: 
 
NAME:    AGE/SEX:    IP NO.: 
DATE:     Wt.:   Ht:  GROUP: 
DIAGNOSIS: 
SURGERY: 
CO-MORBID ILLNESS:      
INVESTIGATIONS: 
Hb:                                       BLOOD UREA:        BLOOD GROUP: 
BLOOD SUGAR:                                             SERUM CREATININE: 
CXR:                                                                 ECG:       
 
ANESTHESIA DETAILS: 
  
TYPE OF ANAESTHESIA: LMAGA WITH SPONTANEOUS RESPIRATION 
ASSESSMENT:  ASA I  / ASA II 
PRE-OP: 
HR:                                BP:                                SPO2: 
CVS:                              RS: 
PREMEDICATION: 
INDUCTION: 
MAINTENANCE: 
 
INTRA-OP: 
TIME HR BP MAP VOLATILE% ETVOLATILE ETCO2 
       
       
       
       
       
       
       
       
       
 ANY OTHER DRUGS GIVEN: 
 T IME TO ACHIEVE DESIRED END TIDAL CONCENTRATION: 
 TOTAL DURATION OF ANAESTHESIA 
 TOTAL DURATION OF SURGERY: 
 TIME OF DISCONTINUATION OF VOLATILE AGENT (TIME 0):  
 TIME OF DISCONTINUATION OF NITROUS OXIDE: 
 
 
RECOVERY TIME FROM THE DISCONTINUATION OF INHALED AGENT (mins): 
 
 RESPONSE TO PAINFUL STIMULUS: 
 RESPONSE TO VERBAL COMMANDS: 
 SPONTANEOUS EYE OPENING: 
 TIME OF LMA REMOVAL: 
 RECALL OF NAME 
  PARS >10 
 ANY AIRWAY ADVERSE EFFECTS: 
 
POSTOPERATIVE COMPLICATIONS (IF ANY): 
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1 02/06/2017 1711973 LAKSHMI I 50 D 3.42                        43.00                       54.00 4 5 8 8
2 02/11/2017 1705945 NAFEEZA I 35 S 4.22                        44.00                       54.00 4 4 9 10
3 15/2/2017 1708016 NITHYA KUMARI I 48 D 3.58                        42.00                       56.00 5 5 10 11
4 17/2/2017 17089312 FATHIMA I 19 S 4.15                        45.00                       58.00 4 5 9 10
5 22/2/2017 1706269 RAMANI I 44 D 3.54                        35.00                       48.00 3 6 8 9
6 03/02/2017 1711377 ZAIRABANU I 29 S 4.26                        40.00                       54.00 3 8 9 10
7 25/3/2017 1714397 AROKIYAM I 43 S 3.47                        36.00                       46.00 5 7 9 12
8 04/05/2017 1718065 DHANABAKIYAM I 28 S 4.14                        44.00                       56.00 5 6 9 10
9 04/06/2017 1718473 JANSIRANI I 20 D 3.42                        44.00                       57.00 5 6 9 10
10 04/08/2017 1718309 MEENA I 22 D 3.28                        35.00                       44.00 4 5 10 12
11 04/10/2017 567310 SHAMEENA II 21 D 3.39                        46.00                       56.00 4 8 9 10
12 18/4/2017 1720026 AMUDHA I 41 S 4.04                        48.00                       56.00 7 7 8 10
13 21/4/2017 1722449 AFRINBANU I 18 D 3.23                        53.00                       59.00 7 8 8 9
14 22/4/2017 1721515 MANJULA I 35 S 4.03                        45.00                       53.00 2 6 8 10
15 22/4/2017 1717286 PAVITHRA I 17 D 3.41                        36.00                       42.00 5 8 7 8
16 05/06/2017 1722870 SUMATHI I 36 S 4.12                        44.00                       52.00 5 6 8 10
17 05/10/2017 123060 JAYANTHI I 20 D 3.54                        46.00                       53.00 6 7 8 9
18 17/5/2017 1715127 LALITHA I 42 S 4.21                        38.00                       47.00 5 5 9 10
19 17/5/2017 1715146 VARSHINI I 19 S 4.08                        40.00                       48.00 3 6 10 12
20 18/5/2017 1727036 TAMILSELVI II 17 D 3.49                        42.00                       51.00 6 6 7 8
21 19/5/2017 1727103 MADHUMATHI I 20 D 3.54                        37.00                       46.00 4 7 9 10
22 22/5/2017 1727775 ANANDHI I 19 S 4.12                        41.00                       48.00 4 7 8 10
23 23/5/2017 1727264 MYTHILI I 29 S 4.11                        52.00                       58.00 3 5 8 10
24 26/5/2017 1728189 VARSHINI I 19 D 3.52                        46.00                       53.00 4 6 8 9
25 28/5/2017 1730552 TAMILSELVI I 27 D 3.47                        42.00                       50.00 5 4 7 8
26 29/5/2017 1723404 DHARSHINI II 13 D 3.44                        34.00                       41.00 2 8 7 8
27 29/5/2017 1708633 DHANALAKSHMI II 39 S 4.1                        39.00                       46.00 6 7 9 10
28 06/01/2017 37783 LATHA I 38 S 4.09                        42.00                       51.00 4 6 10 12
29 06/01/2017 1729957 DHANALAKSHMI I 44 D 3.52                        37.00                       45.00 6 6 8 9
30 06/06/2017 1707810 KARTHIKA I 24 S 4.21                        36.00                       44.00 3 8 7 8
31 06/06/2017 1730643 SAROJA I 50 S 4.18                        43.00                       49.00 6 7 9 10
32 06/12/2017 1730387 DEEPA II 20 S 4.16                        26.00                       32.00 4 7 10 12
33 17/6/2017 1732850 ASAIVENI I 40 D 3.38                        36.00                       43.00 5 7 8 9
RECOVERY CHART
TOTAL 
DURATION OF 
SURGERY 
[mins]
S. NO GROUPAGEASA PSNAMEDATE
TIME TO ACHIEVE 
DESIRED END TIDAL 
CONCENTRATION(MI
NS)
RESPONSE 
TO VERBAL 
COMMANDS 
(mins)
IP NO
RESPONSE 
TO PAIN 
(mins)
TIME OF 
DISCONT OF 
NITROUS (mins)
TOTAL 
DURATION OF 
ANAESTHESIA 
[mins]
SPONTANEOUS 
EYE OPENING 
(mins)
TOTAL 
DURATION OF 
SURGERY 
[mins]
S. NO GROUPAGEASA PSNAMEDATE
TIME TO ACHIEVE 
DESIRED END TIDAL 
CONCENTRATION(MI
NS)
RESPONSE 
TO VERBAL 
COMMANDS 
(mins)
IP NO
RESPONSE 
TO PAIN 
(mins)
TIME OF 
DISCONT OF 
NITROUS (mins)
TOTAL 
DURATION OF 
ANAESTHESIA 
[mins]
SPONTANEOUS 
EYE OPENING 
(mins)
34 29/6/2017 1735197 PAVITHRA I 21 S 4.14                        43.00                       51.00 5 7 10 12
35 07/08/2017 1735360 VALLI II 35 D 3.41                        42.00                       49.00 5 7 9 10
36 07/12/2017 1726630 GAYATHRI I 25 S 4.02                        38.00                       44.00 4 6 8 10
37 18/07/2017 1738834 AKILA I 19 D 3.44                        42.00                       49.00 3 9 7 8
38 28/07/2017 1742302 MOHANA I 29 S 4.11                        39.00                       46.00 6 5 10 12
39 06/06/2017 1742310 JEYAPRIYA I 15 D 3.42                        44.00                       53.00 3 7 6 8
40 06/10/2017 1732008 RANJITHA I 25 S 4.09                        33.00                       44.00 4 6 9 10
41 06/12/2017 1732014 RENUGA DEVI I 19 D 3.37                        38.00                       46.00 4 6 8 9
42 15/6/2017 1732498 PANTHANAM I 20 D 3.46                        42.00                       50.00 4 7 9 10
43 24/6/2017 1732534 MANYAKARASI I 15 S 4.03                        44.00                       51.00 5 8 9 10
44 28/6/2017 1735333 NANCY I 25 S 4.12                        36.00                       43.00 5 7 9 10
45 07/10/2017 1737881 LALITHA I 38 D 3.48                        47.00                       54.00 5 8 8 9
46 19/7/2017 1711902 TAMILRANI I 30 D 3.49                        44.00                       52.00 6 6 10 12
47 24/7/2017 1740977 REKHA II 24 S 4.14                        29.00                       35.00 3 6 8 10
48 08/03/2017 1741642 SELVI I 41 D 3.41                        52.00                       58.00 5 7 9 10
49 14/8/2017 1741750 NIVEDHITA I 25 S 4.21                        44.00                       53.00 5 5 7 8
50 14/8/2017 1744041 ASHWINI I 19 D 3.43                        36.00                       44.00 3 7 8 8
51 21/8/2017 1747301 JAMUNA II 38 S 4.11                        38.00                       46.00 3 5 9 10
52 24/8/2017 1712296 SELVI I 35 D 3.52                        42.00                       51.00 3 8 8 9
53 31/8/2017 1745829 BHAVANI I 37 S 4.18                        38.00                       45.00 5 5 8 10
54 08/03/2017 1741642 SELVI II 40 D 3.36                        27.00                       34.00 4 6 9 10
55 14/8/2017 1742658 NIVEDHA I 19 D 3.42                        34.00                       41.00 5 8 8 8
56 24/8/2017 1748218 SELVI I 30 S 4.06                        33.00                       40.00 6 8 10 12
57 31/8/2017 1745829 BHARANI I 34 S 4.13                        29.00                       36.00 5 7 9 10
58 09/11/2017 1745948 KALA I 34 D 3.52                        36.00                       42.00 6 8 9 10
59 13/9/2017 1746014 PARVATHY I 21 S 4.21                        38.00                       45.00 3 7 8 10
60 14/9/2017 1746234 SARASWATHY I 46 S 4.16                        40.00                       47.00 3 7 10 12
1 02/06/2017 1711973 LAKSHMI
2 02/11/2017 1705945 NAFEEZA
3 15/2/2017 1708016 NITHYA KUMARI
4 17/2/2017 17089312 FATHIMA
5 22/2/2017 1706269 RAMANI
6 03/02/2017 1711377 ZAIRABANU
7 25/3/2017 1714397 AROKIYAM
8 04/05/2017 1718065 DHANABAKIYAM
9 04/06/2017 1718473 JANSIRANI
10 04/08/2017 1718309 MEENA
11 04/10/2017 567310 SHAMEENA
12 18/4/2017 1720026 AMUDHA
13 21/4/2017 1722449 AFRINBANU
14 22/4/2017 1721515 MANJULA
15 22/4/2017 1717286 PAVITHRA
16 05/06/2017 1722870 SUMATHI
17 05/10/2017 123060 JAYANTHI
18 17/5/2017 1715127 LALITHA
19 17/5/2017 1715146 VARSHINI
20 18/5/2017 1727036 TAMILSELVI
21 19/5/2017 1727103 MADHUMATHI
22 22/5/2017 1727775 ANANDHI
23 23/5/2017 1727264 MYTHILI
24 26/5/2017 1728189 VARSHINI
25 28/5/2017 1730552 TAMILSELVI
26 29/5/2017 1723404 DHARSHINI
27 29/5/2017 1708633 DHANALAKSHMI
28 06/01/2017 37783 LATHA
29 06/01/2017 1729957 DHANALAKSHMI
30 06/06/2017 1707810 KARTHIKA
31 06/06/2017 1730643 SAROJA
32 06/12/2017 1730387 DEEPA
33 17/6/2017 1732850 ASAIVENI
S. NO NAMEDATE IP NO
8 10 11 1 YES GRADE 1 95% no no
10 11 12 1 NO no      no no no
11 11 13 1 YES GRADE 1      no no no
10 10 12 1 NO no      no no no
9 9 10 1 YES GRADE 1      no no no
10 10 13 2 NO no      no no no
12 13 15 1 NO no      no no no
10 10 13 1 NO no      no no no
10 10 12 1 NO no      no no no
12 13 15 2 YES GRADE 1      no no no
10 10 13 1 NO no      no no no
10 10 13 1 NO no      no no no
9 9 10 1 NO no      no no no
10 10 13 2 NO no      no no no
8 9 10 1 YES GRADE 1 95% no no
10 10 13 2 NO no      no no no
9 9 10 1 NO no      no no no
10 10 13 1 NO no      no no no
12 13 15 1 YES GRADE1 95% no no
8 9 10 1 YES GRADE1      no no no
10 10 12 1 NO no      no no no
10 10 13 1 NO no      no no no
10 10 13 1 NO no      no no no
9 9 10 1 NO no      no no no
8 10 10 2 NO no      no no no
8 9 10 1 NO no      no no no
10 10 12 1 NO no      no no no
12 13 15 1 NO no      no no no
9 9 10 1 YES GRADE1      no no no
8 9 10 1 NO no      no no no
10 10 13 1 NO no      no no no
12 13 15 1 NO no      no no no
9 9 10 1 NO no      no no no
PONV
LARYNGO
SPASM
SPO2<_95
% IN 5 
MINUTES
COUGH
ANY AIRWAY 
ADVERSE 
EFFECTS  
NO OF 
ATTEMPTS OF 
LMA 
INSERTION
PARS >10 
(mins)
RECALL OF 
NAME (mins)
TIME OF LMA 
REMOVAL 
(MINS)
S. NO NAMEDATE IP NO
34 29/6/2017 1735197 PAVITHRA
35 07/08/2017 1735360 VALLI
36 07/12/2017 1726630 GAYATHRI
37 18/07/2017 1738834 AKILA
38 28/07/2017 1742302 MOHANA
39 06/06/2017 1742310 JEYAPRIYA
40 06/10/2017 1732008 RANJITHA
41 06/12/2017 1732014 RENUGA DEVI
42 15/6/2017 1732498 PANTHANAM
43 24/6/2017 1732534 MANYAKARASI
44 28/6/2017 1735333 NANCY
45 07/10/2017 1737881 LALITHA
46 19/7/2017 1711902 TAMILRANI
47 24/7/2017 1740977 REKHA
48 08/03/2017 1741642 SELVI
49 14/8/2017 1741750 NIVEDHITA
50 14/8/2017 1744041 ASHWINI
51 21/8/2017 1747301 JAMUNA
52 24/8/2017 1712296 SELVI
53 31/8/2017 1745829 BHAVANI
54 08/03/2017 1741642 SELVI
55 14/8/2017 1742658 NIVEDHA
56 24/8/2017 1748218 SELVI
57 31/8/2017 1745829 BHARANI
58 09/11/2017 1745948 KALA
59 13/9/2017 1746014 PARVATHY
60 14/9/2017 1746234 SARASWATHY
PONV
LARYNGO
SPASM
SPO2<_95
% IN 5 
MINUTES
COUGH
ANY AIRWAY 
ADVERSE 
EFFECTS  
NO OF 
ATTEMPTS OF 
LMA 
INSERTION
PARS >10 
(mins)
RECALL OF 
NAME (mins)
TIME OF LMA 
REMOVAL 
(MINS)
12 13 15 1 NO no      no no no
10 10 12 1 NO no      no no no
10 10 13 1 NO no      no no no
8 9 10 1 YES GRADE1      no no no
12 13 15 1 NO no      no no no
9 9 10 2 NO no      no no no
10 10 13 1 NO no      no no no
9 9 10 1 NO no      no no no
10 10 12 1 YES no      no no no
10 10 13 2 NO no      no no no
10 10 13 1 NO no      no no no
9 9 10 1 NO no      no no no
12 13 15 1 YES GRADE 1      no no no
10 10 13 1 NO no      no no no
10 10 12 2 NO no      no no no
8 9 10 1 NO no      no no no
8 9 11 1 NO no      no no no
10 10 13 1 NO no      no no no
9 9 10 1 NO no      no no no
10 10 13 1 N0 no      no no no
10 10 12 1 NO no      no no no
8 9 11 1 NO no      no no no
12 13 15 1 NO no      no no no
10 10 13 1 NO no      no no no
10 10 12 1 NO no      no no no
10 10 13 1 NO no      no no no
12 13 15 1 NO no      no no no
1 02/06/2017 1711973 LAKSHMI I 50 D 85 80 94 82 84 82
2 02/11/2017 1705945 NAFEEZA I 35 S 82 78 90 80 90 88
3 15/2/2017
1708016
NITHYA KUMARI I 48 D 96 92 105 95 97 96
4 17/2/2017 17089312 FATHIMA I 19 S 76 70 84 70 74 72
5 22/2/2017 1706269 RAMANI I 44 D 82 75 90 80 84 86
6 03/02/2017 1711377 ZAIRABANU I 29 S 80 76 88 76 82 78
7 25/3/2017 1714397 AROKIYAM I 43 S 76 70 84 74 74 70
8 04/05/2017
1718065
DHANABAKIYAM I 28 S 84 78 90 80 82 78
9 04/06/2017 1718473 JANSIRANI I 20 D 89 82 96 87 92 86
10 04/08/2017 1718309 MEENA I 22 D 95 90 103 93 96 90
11 04/10/2017 567310 SHAMEENA II 21 D 92 88 101 91 94 90
12 18/4/2017 1720026 AMUDHA I 41 S 90 86 98 88 80 78
13 21/4/2017 1722449 AFRINBANU I 18 D 80 72 99 77 80 79
14 22/4/2017 1721515 MANJULA I 35 S 76 70 84 72 74 72
15 22/4/2017 1717286 PAVITHRA I 17 D 100 92 108 98 102 101
16 05/06/2017 1722870 SUMATHI I 36 S 88 80 96 86 86 86
17 05/10/2017 123060 JAYANTHI I 20 D 72 68 80 70 74 70
18 17/5/2017 1715127 LALITHA I 42 S 76 70 84 75 74 73
19 17/5/2017 1715146 VARSHINI I 19 S 68 64 76 67 66 65
20 18/5/2017 1727036 TAMILSELVI II 17 D 76 72 83 75 79 75
21 19/5/2017 1727103 MADHUMATHI I 20 D 93 87 101 92 96 93
22 22/5/2017 1727775 ANANDHI I 19 S 92 86 104 90 96 90
23 23/5/2017 1727264 MYTHILI I 29 S 80 74 88 79 85 79
24 26/5/2017 1728189 VARSHINI I 19 D 89 82 97 88 92 90
25 28/5/2017 1730552 TAMILSELVI I 27 D 75 70 82 74 78 74
26 29/5/2017 1723404 DHARSHINI II 13 D 95 90 104 90 94 92
27 29/5/2017
1708633
DHANALAKSHMI II 39 S 92 86 93 87 93 88
28 06/01/2017 37783 LATHA I 38 S 78 72 87 77 86 76
29 06/01/2017
1729957
DHANALAKSHMI I 44 D 97 89 108 88 94 91
HR SKIN 
INCISION
HR 10 
MINS
GROUP
HR 
PREINDUCTI
ON
HR 
INDUCTION
HR POST LMA 
PLACEMENT
HR 
5MINS
AGES. No DATE IP NO NAME ASA PS
HR SKIN 
INCISION
HR 10 
MINS
GROUP
HR 
PREINDUCTI
ON
HR 
INDUCTION
HR POST LMA 
PLACEMENT
HR 
5MINS
AGES. No DATE IP NO NAME ASA PS
30 06/06/2017 1707810 KARTHIKA I 24 S 88 82 96 87 86 84
31 06/06/2017 1730643 SAROJA I 50 S 74 68 82 72 78 72
32 06/12/2017 1730387 DEEPA II 20 S 76 70 84 75 78 74
33 17/6/2017 1732850 ASAIVENI I 40 D 81 75 88 74 78 75
34 29/6/2017 1735197 PAVITHRA I 21 S 85 80 93 82 88 86
35 07/08/2017 1735360 VALLI II 35 D 83 78 90 77 81 78
36 07/12/2017 1726630 GAYATHRI I 25 S 82 75 91 81 84 83
37 18/07/2017 1738834 AKILA I 19 D 79 72 86 70 74 70
38 28/07/2017 1742302 MOHANA I 29 S 95 90 104 93 96 93
39 06/06/2017 1742310 JEYAPRIYA I 15 D 95 90 103 89 94 90
40 06/10/2017 1732008 RANJITHA I 25 S 76 72 84 75 79 78
41 06/12/2017 1732014 RENUGA DEVI I 19 D 72 68 80 69 76 72
42 15/6/2017 1732498 PANTHANAM I 20 D 102 94 110 95 98 96
43 24/6/2017 1732534 MANYAKARASI I 15 S 93 87 102 92 96 94
44 28/6/2017 1735333 NANCY I 25 S 89 82 96 87 90 88
45 07/10/2017 1737881 LALITHA I 38 D 76 70 81 71 75 72
46 19/7/2017 1711902 TAMILRANI I 30 D 85 79 95 78 83 80
47 24/7/2017 1740977 REKHA II 24 S 83 78 91 80 84 82
48 08/03/2017 1741642 SELVI I 41 D 82 78 92 81 86 85
49 14/8/2017 1741750 NIVEDHITA I 25 S 81 75 89 80 84 82
50 14/8/2017 1744041 ASHWINI I 19 D 75 70 84 72 75 73
51 21/8/2017 1747301 JAMUNA II 38 S 74 68 83 72 76 75
52 24/8/2017 1712296 SELVI I 35 D 76 70 82 74 77 75
53 31/8/2017 1745829 BHAVANI I 37 S 88 82 96 86 90 88
54 08/03/2017 1741642 SELVI II 40 D 95 91 104 94 96 95
55 14/8/2017 1742658 NIVEDHA I 19 D 86 78 98 82 86 85
56 24/8/2017 1748218 SELVI I 30 S 92 86 101 90 94 93
57 31/8/2017 1745829 BHARANI I 34 S 79 73 88 77 84 82
58 09/11/2017 1745948 KALA I 34 D 84 76 93 80 88 87
59 13/9/2017 1746014 PARVATHY I 21 S 84 79 91 82 87 85
60 14/9/2017 1746234 SARASWATHY I 46 D 88 80 95 85 89 88
1 02/06/2017 1711973 LAKSHMI
2 02/11/2017 1705945 NAFEEZA
3 15/2/2017
1708016
NITHYA KUMARI
4 17/2/2017 17089312 FATHIMA
5 22/2/2017 1706269 RAMANI
6 03/02/2017 1711377 ZAIRABANU
7 25/3/2017 1714397 AROKIYAM
8 04/05/2017
1718065
DHANABAKIYAM
9 04/06/2017 1718473 JANSIRANI
10 04/08/2017 1718309 MEENA
11 04/10/2017 567310 SHAMEENA
12 18/4/2017 1720026 AMUDHA
13 21/4/2017 1722449 AFRINBANU
14 22/4/2017 1721515 MANJULA
15 22/4/2017 1717286 PAVITHRA
16 05/06/2017 1722870 SUMATHI
17 05/10/2017 123060 JAYANTHI
18 17/5/2017 1715127 LALITHA
19 17/5/2017 1715146 VARSHINI
20 18/5/2017 1727036 TAMILSELVI
21 19/5/2017 1727103 MADHUMATHI
22 22/5/2017 1727775 ANANDHI
23 23/5/2017 1727264 MYTHILI
24 26/5/2017 1728189 VARSHINI
25 28/5/2017 1730552 TAMILSELVI
26 29/5/2017 1723404 DHARSHINI
27 29/5/2017
1708633
DHANALAKSHMI
28 06/01/2017 37783 LATHA
29 06/01/2017
1729957
DHANALAKSHMI
S. No DATE IP NO NAME
80 78 79 88
86 78 76 90
94 92 90 95
71 70 68 80
82 81 80 86
76 74 74 88
68 72 68 84
76 70 70 92
84 80 78 92
88 86 86 98
88 86 86 97
76 76 74 88
78 77 76 88
70 73 70 84
99 98 97 106
84 84 83 82
73 69 68 78
72 70 68 84
65 64 62 76
74 72 71 82
91 90 89 97
88 88 86 98
76 74 72 82
89 86 85 94
72 72 70 83
91 89 88 100
89 86 87 98
74 72 72 84
90 88 88 105
HR 
15MINS
HR 30 
MINS
HR 45 
MINS
HR 60 
MINS
S. No DATE IP NO NAME
30 06/06/2017 1707810 KARTHIKA
31 06/06/2017 1730643 SAROJA
32 06/12/2017 1730387 DEEPA
33 17/6/2017 1732850 ASAIVENI
34 29/6/2017 1735197 PAVITHRA
35 07/08/2017 1735360 VALLI
36 07/12/2017 1726630 GAYATHRI
37 18/07/2017 1738834 AKILA
38 28/07/2017 1742302 MOHANA
39 06/06/2017 1742310 JEYAPRIYA
40 06/10/2017 1732008 RANJITHA
41 06/12/2017 1732014 RENUGA DEVI
42 15/6/2017 1732498 PANTHANAM
43 24/6/2017 1732534 MANYAKARASI
44 28/6/2017 1735333 NANCY
45 07/10/2017 1737881 LALITHA
46 19/7/2017 1711902 TAMILRANI
47 24/7/2017 1740977 REKHA
48 08/03/2017 1741642 SELVI
49 14/8/2017 1741750 NIVEDHITA
50 14/8/2017 1744041 ASHWINI
51 21/8/2017 1747301 JAMUNA
52 24/8/2017 1712296 SELVI
53 31/8/2017 1745829 BHAVANI
54 08/03/2017 1741642 SELVI
55 14/8/2017 1742658 NIVEDHA
56 24/8/2017 1748218 SELVI
57 31/8/2017 1745829 BHARANI
58 09/11/2017 1745948 KALA
59 13/9/2017 1746014 PARVATHY
60 14/9/2017 1746234 SARASWATHY
HR 
15MINS
HR 30 
MINS
HR 45 
MINS
HR 60 
MINS
86 84 82 94
70 68 70 80
72 70 70 84
72 71 70 86
85 83 84 92
77 75 75 89
82 80 79 88
71 69 70 84
92 90 88 96
88 86 84 102
75 74 72 83
72 71 70 78
94 93 90 105
91 90 88 96
86 85 84 95
70 68 69 84
78 76 76 89
81 80 79 87
84 83 82 89
81 80 78 87
72 70 70 80
73 72 71 79
74 72 71 82
87 85 84 94
93 92 90 99
84 82 80 92
92 90 88 98
81 80 80 87
85 84 83 90
84 83 82 90
85 84 82 94
SBP DBP Mean SBP DBP MEAN SBP DBP MEAN SBP DBP MAP SBP DBP MEAN
1 02/06/2017 1711973 LAKSHMI I 50 D 104 78 86 99 60 72 120 96 103 110 72 83 114 62 78
2 02/11/2017 1705945 NAFEEZA I 35 S 112 70 83 98 65 75 123 98 106 112 74 85 110 58 74
3 15/2/2017
1708016
NITHYA KUMARI I 48 D 108 74 84 96 53 66 115 91 98 115 75 87 102 65 76
4 17/2/2017 17089312 FATHIMA I 19 S 106 78 86 99 56 69 116 90 98 110 74 85 102 62 74
5 22/2/2017 1706269 RAMANI I 44 D 122 80 93 100 59 71 120 86 96 100 65 76 103 60 73
6 03/02/2017 1711377 ZAIRABANU I 29 S 107 74 84 97 51 65 130 89 101 100 64 75 104 58 72
7 25/3/2017 1714397 AROKIYAM I 43 S 115 71 84 100 50 65 125 85 97 125 64 82 106 56 71
8 04/05/2017
1718065
DHANABAKIYAM I 28 S 109 75 85 102 58 71 126 74 90 102 68 78 110 66 79
9 04/06/2017 1718473 JANSIRANI I 20 D 120 74 88 95 56 68 120 78 91 125 69 86 112 62 77
10 04/08/2017 1718309 MEENA I 22 D 123 79 92 94 59 70 116 89 97 116 72 85 130 63 83
11 04/10/2017 567310 SHAMEENA II 21 D 109 80 89 96 60 71 119 85 95 119 68 83 105 62 75
12 18/4/2017 1720026 AMUDHA I 41 S 107 84 91 92 61 70 118 89 98 118 69 84 108 66 79
13 21/4/2017 1722449 AFRINBANU I 18 D 104 82 89 93 66 74 120 87 97 102 65 76 106 64 77
14 22/4/2017 1721515 MANJULA I 35 S 109 81 89 90 62 70 123 78 92 125 75 90 104 68 79
15 22/4/2017 1717286 PAVITHRA I 17 D 107 74 84 102 56 70 120 75 89 124 65 83 106 60 74
16 05/06/2017 1722870 SUMATHI I 36 S 106 77 86 94 54 66 116 79 90 117 64 80 105 62 75
17 05/10/2017 123060 JAYANTHI I 20 D 108 74 84 96 59 70 115 78 89 118 62 79 103 64 76
18 17/5/2017 1715127 LALITHA I 42 S 122 73 88 98 69 78 119 72 86 119 63 80 102 64 75
19 17/5/2017 1715146 VARSHINI I 19 S 109 72 83 100 65 76 124 82 95 125 69 86 100 68 78
20 18/5/2017 1727036 TAMILSELVI II 17 D 115 70 84 93 52 64 127 83 96 102 68 78 104 62 75
21 19/5/2017 1727103 MADHUMATHI I 20 D 104 65 77 100 53 67 128 86 99 116 64 80 108 62 76
22 22/5/2017 1727775 ANANDHI I 19 S 123 75 89 100 51 66 123 87 98 110 65 79 110 64 78
23 23/5/2017 1727264 MYTHILI I 29 S 108 74 84 97 59 70 130 85 99 115 63 79 112 68 81
24 26/5/2017 1728189 VARSHINI I 19 D 122 64 81 98 55 68 120 95 103 119 65 81 114 70 83
25 28/5/2017 1730552 TAMILSELVI I 27 D 106 61 75 93 54 66 125 90 101 114 67 81 120 57 76
26 29/5/2017 1723404 DHARSHINI II 13 D 113 66 80 91 56 67 116 84 94 125 61 80 121 56 76
27 29/5/2017
1708633
DHANALAKSHMI II 39 S 104 67 78 90 60 69 119 85 95 126 62 81 116 55 73
28 06/01/2017 37783 LATHA I 38 S 119 62 79 96 55 67 118 89 98 114 60 76 118 54 73
29 06/01/2017
1729957
DHANALAKSHMI I 44 D 115 68 82 95 54 66 123 86 97 119 63 80 110 56 72
30 06/06/2017 1707810 KARTHIKA I 24 S 108 80 88 98 57 69 119 82 93 120 69 84 118 57 75
31 06/06/2017 1730643 SAROJA I 50 S 128 63 83 94 58 69 120 78 91 118 75 88 116 59 76
32 06/12/2017 1730387 DEEPA II 20 S 118 69 84 95 59 70 125 87 98 117 78 90 114 58 75
33 17/6/2017 1732850 ASAIVENI I 40 D 109 70 82 96 51 65 109 89 95 119 70 85 118 56 75
POST INDUCTION POST LMA INSERTION SKIN INCISION AT 5 MINUTES
GROUPAGE
PRE INDUCTIONS. 
No
DATE IP NO NAME ASA PS
SBP DBP Mean SBP DBP MEAN SBP DBP MEAN SBP DBP MAP SBP DBP MEAN
POST INDUCTION POST LMA INSERTION SKIN INCISION AT 5 MINUTES
GROUPAGE
PRE INDUCTIONS. 
No
DATE IP NO NAME ASA PS
34 29/6/2017 1735197 PAVITHRA I 21 S 104 71 81 92 52 64 124 79 93 120 62 79 112 66 80
35 07/08/2017 1735360 VALLI II 35 D 121 72 87 93 56 67 127 76 91 130 67 86 110 67 80
36 07/12/2017 1726630 GAYATHRI I 25 S 108 78 87 89 59 68 128 75 91 116 75 87 114 62 78
37 18/07/2017 1738834 AKILA I 19 D 107 79 87 88 65 72 129 78 93 114 69 83 116 65 80
38 28/07/2017 1742302 MOHANA I 29 S 117 75 88 100 69 78 125 77 91 119 62 79 114 62 78
39 06/06/2017 1742310 JEYAPRIYA I 15 D 104 74 83 93 68 76 126 71 88 100 68 78 116 65 80
40 06/10/2017 1732008 RANJITHA I 25 S 109 86 93 106 50 67 129 73 90 105 64 76 118 56 75
41 06/12/2017 1732014 RENUGA DEVI I 19 D 106 66 78 102 52 67 130 70 88 105 61 74 114 58 75
42 15/6/2017 1732498 PANTHANAM I 20 D 115 65 80 100 51 66 116 74 87 109 63 77 106 68 79
43 24/6/2017
1732534
MANYAKARASI I 15 S 109 72 83 96 53 66 119 87 97 119 69 84 108 65 78
44 28/6/2017 1735333 NANCY I 25 S 107 77 86 95 55 67 120 89 98 108 68 80 102 58 71
45 07/10/2017 1737881 LALITHA I 38 D 123 61 80 98 56 69 133 85 99 116 64 80 108 56 72
46 19/7/2017 1711902 TAMILRANI I 30 D 118 63 80 97 59 70 128 78 93 117 69 83 106 56 71
47 24/7/2017 1740977 REKHA II 24 S 104 69 80 95 55 67 129 75 91 120 69 84 104 68 79
48 08/03/2017 1741642 SELVI I 41 D 107 78 87 89 58 67 125 79 93 116 65 80 108 65 78
49 14/8/2017 1741750 NIVEDHITA I 25 S 109 68 80 90 55 66 120 72 86 116 68 82 110 64 78
50 14/8/2017 1744041 ASHWINI I 19 D 116 69 83 91 54 65 113 74 86 122 63 81 106 64 77
51 21/8/2017 1747301 JAMUNA II 38 S 104 70 80 96 59 70 126 76 91 112 60 76 108 66 79
52 24/8/2017 1712296 SELVI I 35 D 125 61 80 100 56 69 110 75 86 130 61 82 103 62 74
53 31/8/2017 1745829 BHAVANI I 37 S 113 63 78 98 65 75 118 84 94 140 69 90 114 62 78
54 08/03/2017 1741642 SELVI II 40 D 123 73 88 92 62 71 117 87 96 126 64 83 118 64 80
55 14/8/2017 1742658 NIVEDHA I 19 D 104 78 86 93 56 67 127 89 100 128 69 87 116 68 82
56 24/8/2017 1748218 SELVI I 30 S 109 79 88 94 63 72 128 78 93 130 68 87 112 68 81
57 31/8/2017 1745829 BHARANI I 34 S 107 80 88 96 65 74 124 89 100 132 70 89 110 63 77
58 09/11/2017 1745948 KALA I 34 D 115 65 80 93 58 69 120 87 97 125 67 84 115 64 79
59 13/9/2017 1746014 PARVATHY I 21 S 104 63 75 92 59 69 116 85 94 112 61 76 112 65 79
60 14/9/2017 1746234 SARASWATHY I 46 D 108 69 81 91 51 63 123 75 89 114 70 83 114 62 78
1 02/06/2017 1711973 LAKSHMI
2 02/11/2017 1705945 NAFEEZA
3 15/2/2017
1708016
NITHYA KUMARI
4 17/2/2017 17089312 FATHIMA
5 22/2/2017 1706269 RAMANI
6 03/02/2017 1711377 ZAIRABANU
7 25/3/2017 1714397 AROKIYAM
8 04/05/2017
1718065
DHANABAKIYAM
9 04/06/2017 1718473 JANSIRANI
10 04/08/2017 1718309 MEENA
11 04/10/2017 567310 SHAMEENA
12 18/4/2017 1720026 AMUDHA
13 21/4/2017 1722449 AFRINBANU
14 22/4/2017 1721515 MANJULA
15 22/4/2017 1717286 PAVITHRA
16 05/06/2017 1722870 SUMATHI
17 05/10/2017 123060 JAYANTHI
18 17/5/2017 1715127 LALITHA
19 17/5/2017 1715146 VARSHINI
20 18/5/2017 1727036 TAMILSELVI
21 19/5/2017 1727103 MADHUMATHI
22 22/5/2017 1727775 ANANDHI
23 23/5/2017 1727264 MYTHILI
24 26/5/2017 1728189 VARSHINI
25 28/5/2017 1730552 TAMILSELVI
26 29/5/2017 1723404 DHARSHINI
27 29/5/2017
1708633
DHANALAKSHMI
28 06/01/2017 37783 LATHA
29 06/01/2017
1729957
DHANALAKSHMI
30 06/06/2017 1707810 KARTHIKA
31 06/06/2017 1730643 SAROJA
32 06/12/2017 1730387 DEEPA
33 17/6/2017 1732850 ASAIVENI
S. 
No
DATE IP NO NAME
SBP DBP MEAN SBP DBP MEAN SBP DBP MEAN SBP DBP MEAN
96 68 76 92 64 72 94 62 72 120 82 93
98 70 78 94 62 72 96 64 74 124 84 96
94 74 80 94 60 70 94 62 72 124 78 92
96 64 74 96 61 72 92 68 75 126 88 99
92 68 75 94 67 75 96 66 75 128 56 78
92 64 72 98 62 73 94 66 74 124 84 96
98 63 74 94 64 73 92 68 75 124 82 95
96 66 75 94 66 74 92 64 72 122 84 95
92 62 71 96 68 76 96 62 72 114 84 93
94 62 72 94 62 72 94 70 77 116 82 92
98 64 74 92 61 70 96 68 76 114 78 89
96 62 72 94 64 73 98 64 74 112 80 90
92 64 72 95 62 72 96 64 74 118 82 93
94 66 74 92 64 72 96 62 72 114 74 86
98 69 78 92 60 70 94 60 70 116 78 89
93 63 72 92 54 65 98 62 73 112 76 87
97 67 76 92 54 65 92 62 71 118 74 87
96 66 75 90 72 77 96 64 74 112 72 84
94 64 73 94 59 70 98 68 77 114 76 87
97 68 77 94 58 69 95 65 74 116 78 89
92 58 68 90 50 62 94 63 72 114 74 86
95 54 66 96 52 65 96 62 72 118 78 90
96 56 68 92 52 64 92 64 72 114 78 89
92 54 65 94 54 66 92 62 71 126 74 90
90 74 79 92 52 64 94 62 72 124 75 90
94 52 65 88 56 66 98 64 74 126 76 91
92 84 86 86 58 66 96 64 74 124 78 92
93 76 81 92 54 65 92 64 72 118 72 86
92 75 80 86 54 64 92 64 72 122 78 91
90 45 59 88 70 75 94 62 72 128 84 97
96 62 72 84 54 63 92 62 71 120 84 95
98 75 82 82 54 62 92 64 72 122 84 95
98 45 61 86 56 65 92 62 71 124 82 95
AT 30 MINUTES AT 45 MINUTES AT 60 MINUTESAT 15 MINUTES
S. 
No
DATE IP NO NAME
34 29/6/2017 1735197 PAVITHRA
35 07/08/2017 1735360 VALLI
36 07/12/2017 1726630 GAYATHRI
37 18/07/2017 1738834 AKILA
38 28/07/2017 1742302 MOHANA
39 06/06/2017 1742310 JEYAPRIYA
40 06/10/2017 1732008 RANJITHA
41 06/12/2017 1732014 RENUGA DEVI
42 15/6/2017 1732498 PANTHANAM
43 24/6/2017
1732534
MANYAKARASI
44 28/6/2017 1735333 NANCY
45 07/10/2017 1737881 LALITHA
46 19/7/2017 1711902 TAMILRANI
47 24/7/2017 1740977 REKHA
48 08/03/2017 1741642 SELVI
49 14/8/2017 1741750 NIVEDHITA
50 14/8/2017 1744041 ASHWINI
51 21/8/2017 1747301 JAMUNA
52 24/8/2017 1712296 SELVI
53 31/8/2017 1745829 BHAVANI
54 08/03/2017 1741642 SELVI
55 14/8/2017 1742658 NIVEDHA
56 24/8/2017 1748218 SELVI
57 31/8/2017 1745829 BHARANI
58 09/11/2017 1745948 KALA
59 13/9/2017 1746014 PARVATHY
60 14/9/2017 1746234 SARASWATHY
SBP DBP MEAN SBP DBP MEAN SBP DBP MEAN SBP DBP MEAN
AT 30 MINUTES AT 45 MINUTES AT 60 MINUTESAT 15 MINUTES
96 62 72 88 56 66 92 64 72 120 88 98
94 75 81 82 58 65 92 62 71 124 85 97
98 54 67 84 62 69 94 62 72 114 86 94
92 64 72 86 60 68 96 68 76 116 84 94
90 52 63 94 56 67 94 68 76 118 86 96
94 71 78 98 60 71 101 60 72 118 82 93
98 74 81 96 56 68 102 62 74 120 84 95
96 76 82 94 58 69 104 62 75 120 84 95
92 78 82 96 54 67 104 60 73 124 80 93
92 72 78 88 52 63 108 64 77 124 72 88
90 74 79 89 55 65 104 60 73 126 78 92
94 76 81 92 52 64 110 62 76 124 78 92
98 78 84 90 58 68 112 64 78 128 72 89
91 54 65 90 54 65 110 62 76 124 74 89
96 53 66 86 52 62 114 60 76 124 70 86
94 69 77 90 56 66 112 58 74 128 75 91
92 58 68 90 58 68 110 54 71 130 74 91
90 65 73 94 60 70 114 56 73 140 72 92
92 56 67 92 62 71 112 58 74 136 71 91
90 52 63 88 60 68 110 52 69 132 72 90
90 64 72 95 58 69 106 56 71 124 76 90
94 62 72 96 52 65 108 58 73 124 72 88
92 65 73 94 56 67 108 60 74 124 74 89
94 52 65 92 52 64 104 60 73 128 74 90
96 56 68 94 54 66 108 62 76 132 74 91
98 58 70 92 54 65 104 62 75 132 76 93
94 56 67 92 52 64 102 64 75 142 78 97
